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Sphingolipids are a structurally diverse group of lipids recognized as important
components of cellular membranes and regulators of processes during development and
in response to environmental stresses. Much progress has been made characterizing the
enzymes of the biosynthetic pathway revealing that sphingolipids are essential molecules
in plants and that their synthesis and degradation needs to be tightly regulated. Serine
palmitoyltransferase (SPT) catalyzes the first step in sphingolipid biosynthesis and is a
primary regulatory point for homeostasis. ORM proteins have been identified as negative
regulators of SPT activity, however the mechanistic details of the regulation and other
functional roles of these proteins are only beginning to be understood. In this work, we
show that ORM1 and ORM2 are essential for life cycle completion in Arabidopsis
thaliana. Through the characterization of ORM gene-edited mutants we described that
unregulated sphingolipid biosynthesis resulted in ceramide hyperaccumulation, altered
organellar structures and increased senescence- and pathogenesis-related gene
expression. Furthermore, the study of a structural ORM1 variant provided information
about a transmembrane domain involved in the interaction with SPT.
In this thesis, we also provide insights into the physiological effects caused by
mutations in SPT that induce the production of deoxysphingolipids. Our research

demonstrates that plants expressing these mutations showed early senescence and
reduced sensitivity to the cell death induced by Fumonisin B1. These findings suggest
functional roles of deoxysphingolipids that have not been explored in plants.
Finally, we describe a labeling approach to build a sphingolipid kinetic model to
study the metabolic flux of sphingolipids during pathogen infection. This study considers
a more comprehensive view of the sphingolipid metabolic network that changes
dynamically when perturbed.
Overall, this study encompasses several aspects of sphingolipid biology in plants.
From a directed understanding of the regulatory mechanism and how enzyme variants
can lead to the synthesis of atypical sphingolipids to a more comprehensive
understanding of the metabolic network. The combination of these approaches will
provide important information to understand the regulation of sphingolipids homeostasis.
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Chapter 1 Introduction

1. Sphingolipids
Sphingolipids are a ubiquitously distributed and diverse class of lipids that can be
found in eukaryotic organisms and in some bacteria genus. Their amphiphilic nature
given by a polar head group and two hydrophobic acyl chains make sphingolipids, along
with glycerophospholipids and sterols, structural components of cellular membranes
including plasma membrane (PM), endoplasmic reticulum (ER), Golgi apparatus,
mitochondria and vacuole membranes (Moreau et al., 1998). Crucial physiological
processes that take place at the PM are mediated by glycosphingolipids that can form
platforms for the organization and function of proteins involved in stimulus perception,
signal transduction, protein translocation, endocytosis and cytoskeletal organization
(Kraft et al, 2017; Laloi et al., 2007; Mongrand et al., 2004). Moreover, in plants, these
glycosphingolipids enriched in the outer leaflet of the PM function as receptors of toxins
produced by pathogens and are involved in sensing salt associated with environmental
ionic stress (Jian et al., 2019; Lenarcic et al., 2017). Beyond their function as membrane
components and receptors, other sphingolipid species play crucial roles as signaling
molecules orchestrating environmental responses. Several reports have documented the
roles of sphingolipids in response to drought, low temperatures, pathogenicity and as
triggers of programed cell death and autophagy (Dutilleul et al., 2015; Huby et al., 2020;
Magnin-Robert et al., 2015). In the last decades, a huge progress has been done in the
plant sphingolipid biology field understanding the biosynthetic pathway and the functions
of sphingolipid species in development and response to the environment. This knowledge
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has opened new routes to discover how the cells sense sphingolipids levels and regulate
the biosynthetic pathway in response to specific needs.
1.1.1

Sphingolipid Biosynthesis
In general, there is broad conservation in the way in which sphingolipids are

synthesized in animals, yeast and plants. These lipids can be formed via two pathways:
the de novo pathway, starting with the condensation of a serine with an acyl-CoA, and the
salvage pathway, where complex sphingolipids are catabolized followed by channeling of
the metabolites formed into the synthetic pathway (Merrill, 2002; Hannun & Obeid,
2008; Kitatani et al., 2008).
The unique and defining structural feature of sphingolipids is an amino alcohol
backbone called long-chain base (LCB) or sphingoid base. The simplest and most
common LCB, sphinganine (d18:0), derives from the condensation of serine and
palmitoyl-CoA catalyzed by serine palmitoyltransferase (SPT) and subsequent reduction
of the 3-ketosphinganine product. LCBs can be further modified by hydroxylation,
desaturation, and phosphorylation to yield a range of structural variants (Figure 1.1)
(Markham et al., 2006; Chen, et al., 2009). In mammals, most sphingolipid structures
contain sphingosine with Δ4 unsaturation (d18:1). In contrast, the most widely occurring
LCBs in plants are sphinganine (d18:0), phytosphingosine (t18:0), 4-hydroxy∆8cis/trans-sphingenine (d18:1∆8trans/cis) and ∆4trans, ∆8cis/trans-sphingadiene
(d18:2∆4,∆8) (Figure 1.1) (Lynch and Dunn, 2004; Pruett et al., 2008).
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Figure 1.1 Chemical structures of long chain bases (LCBs).
Shown are examples of dihydroxy and trihydroxy LCBs commonly found in plants. Dihydroxy LCBs
contain hydroxyl groups at C-1 and C-3 positions. Trihydroxy LCBs contain an additional hydroxyl group
at C-4. Dihydroxy and trihidroxy LCBs can contain double bonds at ∆8 position in cis or trans
configuration or in ∆4 position in trans configuration. The nomenclature d18:0 indicates that the LCB has
two hydroxyl groups (d) and 18 carbons with no double bonds.

Free LCBs and their phosphorylated forms typically occur in low concentrations
in eukaryotic cells. In mammals, free LCBs account for less than 1% of the total
sphingolipids in tissues (Alecu et al., 2017), however, they exert signaling functions such
as modulating cell proliferation and apoptosis. In plant cells, free LCBs also serve as a
trigger of programmed cell death (PCD) and are associated pathogen defense responses
(Alden et al., 2011; Zheng et al., 2018; Huby et al., 2019). The majority of LCBs occur
in ceramides and more complex glycosylated sphingolipids.
The condensation of an LCB and a fatty acyl-CoA to form ceramides is catalyzed
by ceramide synthases. Ceramide synthases have defined substrate specificities that result
in ceramides with distinct pairings of structurally diverse LCBs and fatty acids (Markham
et al., 2011; Ternes et al., 2011; Luttgeharm, et al., 2015a, Chen, et al., 2015). In yeast,
the two ceramide synthases, Lag1p and Lac1p, have specificity for C26-acyl CoAs to
form ceramide (Guillas et al., 2001). In contrast, six isoforms of ceramide synthases
(CerS1-6) are expressed in mammals. Each isoform distinctly prefers to incorporate fatty
acids of different chain lengths (C14-C32) into ceramides, this depends on the expression
of the isoforms in certain cell type and environmental conditions (Levy and Futerman,
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2010). In Arabidopsis thaliana (Arabidopsis), two classes of ceramide synthases have
been identified. Class I, encoded by Longevity Assurance Gene One Homolog2 (LOH2),
mostly uses C16-acyl-CoAs to form ceramides and class II, encoded by LOH1 and
LOH3, act on acyl-CoAs containing more than 22 carbons (Ternes et al., 2011;
Luttgeharm et al., 2015).
Ceramides provide the hydrophobic backbone to generate a variety of more
complex sphingolipids. In yeast, ceramides can be further modified to yield abundant
species including inositolphosphorylceramides (IPCs) and the glycosylated
derivatives: mannose inositolphosphoceramide (MIPC) and mannose-(inositol-P)2ceramide M(IP)2C (Dickson, 2010).
In plants, glucosylceramides (GlcCer) and glycosylinositolphosphoceramides
(GIPCs) are the most abundant sphingolipids (Gronnier et al., 2016; Markham et al.,
2006). GlcCer is the simplest glycosphingolipid that occurs broadly in eukaryotes, but not
in Saccharomyces cerevisiae. GlcCer synthase is the ER-localized enzyme that catalyzes
the condensation of ceramide with UDP-glucose (Leipelt et al., 2001). GlcCer are
enriched with C16-ceramides and dihydroxy-LCBs (Markham et al., 2006). According to
this composition, it has been suggested that the ceramide synthase Class I (LOH2) has
preference for channeling the substrates to the formation of GlcCer. In contrast, GIPCs
are enriched in ceramides with VLCFA and trihydroxy LCBs formed by the Class II
ceramide synthases LOH1/LOH3 (Markham et al., 2006). Similarly, in the case of
mammalian cells, ceramides are the precursors of GlcCer, galactosylceramides (GalCer)
and other numerous sphingolipids that are absent in plants and fungal cells including
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Figure 1.2 Sphingolipid biosynthesis in Arabidopsis.
Sphingolipid classes are indicated in green. Enzymes and the corresponding genes are indicated in blue.
Solid arrows indicate biosynthesis steps and dashed arrows indicate catabolic steps. Abbreviations: LCB,
Long chain base; SPT, serine palmitoyltransferase; KSR, 3-ketosphinganine reductase; C4-OHase, C4-LCB
hydroxylase; CSI, ceramide synthase class I; CSII, ceramide synthase class II; VLCFA, very long chain
fatty acid, ∆8 Des, D8 desaturase; GCS, glucosylceramide synthase; GlcCerase, glucosylceramidase; IPCS,
inositol phosphoceramide synthase; PI, phosphatidylinositol; DAG, diacylglycerol; CERK, ceramide
kinase.

sphingomyelin, characterized by the presence of a phosphorylcholine headgroup and
gangliosides containing sialic acid residues.
Sphingolipid synthesis is compartmentalized between two organelles in the cell.
The synthesis of LCBs, ceramides and GlcCer takes place in the ER, but further metabolic
steps to generate GIPCs occurs in the Golgi apparatus. As noted earlier, GlcCer contain
higher amounts of C16 fatty acids and dihydroxy LCBs, instead, GIPCs are enriched in
ceramides containing VLCFA and trihydroxy LCBs. In this scenario a selective vesicular
or non-vesicular transport would be needed to for the synthesis of GIPCs in the Golgi
apparatus. In mammals, ceramide is transported from the ER, the site of synthesis, to Golgi
by a non-vesicular mechanism mediated by CERT proteins (Kudo et al., 2008).
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Ceramides can also be deacylated by ceramidases to generate fatty acids and
LCBs which may then be phosphorylated by LCB kinases to produce LCB-P. In
mammalian cells, the sphingosine generated by ceramidases can be then phosphorylated
by an LCB kinase generating sphingosine-1 phosphate (d18:1-P), a potent intra- and
extra-cellular signaling molecule (Mao and Obeid, 2008). While ceramide synthases are
the main route to synthesize ceramides, reverse ceramidase activity also contributes to
ceramide formation (Mao et al., 2000). This ceramide synthase activity involves the
condensation of a fatty acid and an LCB through an acyl-CoA-independent mechanism,
this activity was first described in Saccharomyces cerevisiae for the ceramidases Ypc1
and Ydc1 (Mao et al., 2000). Arabidopsis has one alkaline ceramidase (ACER) and three
neutral ceramidases (NCER1,2,3) that are involved in keeping sphingolipid homeostasis
under environmental stresses (Li et al., 2015; Wu et al., 2015; Zheng et al., 2018),
however, the ceramide synthesis activity has yet to be determined for these enzymes.
Finally, to exit the sphingolipid metabolic network, the phosphorylated forms of
LCBs are substrate for LCB phosphate lyase also known as sphingosine-1-phosphate
lyase (S1P-lyase or DPL1) the enzyme that catabolizes the sphingolipid backbone to
produce ethanolamine phosphate and hexadecenal, both of which can enter the
glycerolipid metabolism (Mao, Saba and Obeid, 1999; Tsegaye et al., 2007).
The pool of different sphingolipid species is in constant dynamic flux and
responds to the metabolic demands on the cell and the biotic and abiotic stresses from the
environment. This balance not only considers the de novo biosynthesis but also the
breakdown of more complex sphingolipid species to give rise to intermediates of the
pathway with a functional role. How cells sense alterations in sphingolipids levels, in
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response to developmental cues or environmental stimulus, and adjust the rates of the
reactions to maintain homeostasis are vital mechanisms which are only recently
beginning to be understood.
1.1.2

Serine Palmitoyltransferase
The de novo sphingolipid biosynthetic pathway begins with SPT, a CoA-

dependent acyltransferase, which typically catalyzes the condensation of L-serine with
palmitoyl coenzyme-A (palmitoyl-CoA) to form 3-ketosphinganine. Besides using Lserine as substrate to form the canonical LCBs, SPT also shows activity towards glycine
and L-alanine to generate an atypical category designated 1-deoxysphigolipids (Chapter
4) (Penno et al., 2010). The reaction catalyzed by SPT is highly conserved across
multiple species even though the downstream enzymes have diverged in such a way to
give rise to some sphingolipid species that are only found in mammals, plants or fungi.
In prokaryotes, SPT is a soluble homodimer with two catalytic sites at the
interphase (Hanada, 2003; Ikushiro et al., 2007; Yard et al., 2007). In eukaryotes, SPT
consists of a heterodimer with two major subunits (LCB1 and LCB2 in yeast; LCB1 and
LCB2a or LCB2b in plants; SPTLC1 and SPTLC2 or SPTLC3 in mammals). A third
subunit is a small protein required for optimal activity. In yeast there is a single isoform
(Tscp3), not required for basal activity but it can increase it by 30 fold. In higher
eukaryotes there are more subunits, in plants (ssSPTa and ssSPTb) or three in the case of
mammals (Kimberlin et al., 2013; Han et al., 2009). These subunits confer acyl-CoA
specificity and can increase the activity by 100 fold.
In mammalian cells, the subunit composition of SPT determines fatty-acyl-CoA
substrates. For example, the complex formed by SPTCL3 and/or ssSPTb allow the use of
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other shorter or longer acyl-CoAs to generate atypical LCBs (Han et al., 2009). While
palmitoyl-CoA is the preferred substrate for the complex SPTLC1/2 ssSPTa, other
combinations with SPTLC3 ssSPTb can use myristoyl (14:0)-CoA and stearoyl (18:0)CoA.
Interestingly, in Arabidopsis, it is only 33 amino acids of ssSPTa which are
required for activation of the SPT heterodimer and for conferring the acyl-CoA
specificity (Kimberlin et al., 2013). A single mutation in ssSPTa (Met25 to Gly) results
in the change of substrate specificity from C16 acyl-CoA to longer substrates (C20).
However, the exact molecular details of how these small proteins stimulate SPT activity
are still unknown and what is the functional effect of the generation of atypical
sphingolipids is also under investigation.
1.1.3

Regulatory Mechanisms of SPT Activity
Sphingolipid metabolism can be regulated at multiple levels, including enzyme

expression, degradation and localization, post-translational modifications, protein-protein
interactions and allosteric mechanisms. These regulatory mechanisms respond to
intracellular sphingolipid levels and to extracellular stimuli. SPT, as the first enzyme of
the pathway, controls the amounts of serine and palmitoyl-CoA that get channeled for
sphingolipid biosynthesis, therefore this step is tightly regulated. The molecular
mechanisms of governing the regulation of SPT are complex and constitute an active area
of research.
The formation of higher order oligomers has been proposed as a mechanism for
regulating SPT activity. In the case of the mammalian SPT, it has been shown that the
functional complex is an octamer of catalytic heterodimers with a molecular mass of
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~480 kDa. This highly organized complex includes the three SPT subunits (SPTLC1,
SPTLC2 and SPTLC3) with a stoichiometry that is in dynamic change (Hornemann, Wei
and Von Eckardstein, 2007). In addition to oligomerization of the SPT complex, changes
in subcellular localization might also be related to the regulation of its activity. Based on
localization studies, the repressed SPT resides to the peripheral ER and the active form in
the perinuclear (Breslow et al., 2010).
1.1.4

ORM Proteins are Regulators of SPT activity
Additional members of the SPT complex are the Orosomucoid or ORM proteins.

There are two isoforms of ORM proteins in yeast (Orm1 and Orm2) and plants (ORM1
and ORM2) and three isoforms of ORMDLs in mammalian cells. These non-catalytic
proteins play a role as negative regulators of SPT activity.
The first evidence of the role of Orm proteins in the regulation of sphingolipid
synthesis revealed that the deletion of Orm1/2 resulted in an increase of sphingolipid
levels compared to wild type cells in yeast (Breslow et al., 2010). Interestingly, the
Δorm1Δorm2 mutant was more sensitive to DTT and tunicamycin, compounds known to
induce unfolded protein response (UPR) and ER stress (Han et al., 2010). Similar results
were obtained using mammalian cells, where downregulation of the three ORMDL
isoforms by siRNAs led to 3-fold increase in ceramide levels (Breslow et al., 2010).
In Saccharomyces cerevisiae, SPT activity is regulated by Orms through posttranscriptional mechanisms in response to sphingolipids availability. This was established
when the inhibition of SPT using myriocin triggered the phosphorylation of Orm proteins
and caused a change in their subcellular localization from cortical to perinuclear ER
(Breslow et al., 2010). When sphingolipid levels are reduced, by decreasing SPT activity,
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Orm proteins get phosphorylated at N-terminal serine residues by the Ypk1 kinase,
downstream of TORC2, releasing SPT from Orm inhibition (Roelants et al., 2011; Sun et
al., 2012). Once sphingolipids have been replenished the ceramide responsive
phosphatase (PP2A) (Sun et al., 2012) dephosphorylates Orms allowing the regulatory
inhibition of SPT. A current model of sphingolipid synthesis regulation in yeast suggests
the formation of higher-order oligomers including Orms and the SPT subunits Lcb1/2
that respond to specific requirements of sphingolipids by modulating SPT activity
(Breslow et al., 2010).
In addition, another layer of regulation is attributed to the phosphorylation at
different serine residues by the kinase NPR1, downstream of TORC1, in response to
limiting complex sphingolipids. In this case, the mechanisms activate complex
sphingolipids synthesis and migration to the plasma membrane where they exert an effect
on the permease to allow the internalization of nutrients (Shimobayashi et al., 2013).
While multiple evidences show that plant and mammalian ORM proteins play a
key role in regulating SPT activity, it is clear that the regulatory mechanisms differ from
those in yeast due to the lack of the phosphorylation sites at the N-terminus of the plant
ORM protein. In this context, recent studies using mammalian cell cultures suggested that
the regulation of SPT by ORMDLs does not require cytosolic proteins or small molecules
like ATP, ruling out the possibility of post-translational modifications like phosphorylation
as a regulatory process (Davis et al., 2019). Instead, the ORM-SPT regulation seems to
respond to ceramide levels. Gupta et al. (2015) described how the induction of SPT activity
increased ORMDL protein levels and blocking ceramide synthases suppressed this
regulation. Additionally, incubation of isolated membranes with soluble ceramides
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strongly inhibited de novo sphingolipid biosynthesis (Davis et al., 2019). These results
indicate that ORMDL proteins might be regulated by an allosteric effect of ceramide or by
a ceramide sensitive protein-protein interaction involving ORMs. However, although some
evidences point to ceramides containing trihydroxy LCBs and VLCFAs as the main
candidates to orchestrate this regulation, the mechanism is still unclear (Davis et al., 2019).
Moreover, another open question is whether each ORMDL isoform is responding to
ceramide levels and regulating SPT in the same way.
1.1.5 Localization and Topology of ORM proteins
ORMs are primarily localized to the ER (Kimberlin et al., 2016). However, recent
reports in plants showed ORMs can also localize in vesicles and in the PM to exert other
functions related to protein degradation by autophagy playing a key role in plant
immunity (Yang et al., 2019).
The ORM proteins form stable complexes with SPT subunits to regulate its
activity, direct binding of Orm1 and Orm2 with Lcb1, Lcb2, and Tsc3 has been reported
in yeast, however the key regions involved in these interactions are not known. Different
biochemical approaches have been used to determine the topology of ORM proteins with
the final goal to predict regions involved in protein-protein interaction and to identify the
allosteric ceramide binding domain. The topology of mammalian ORMDL3 and
ORMDL1 proteins was determined using fluorescence-based protease protection assay
and substituted cysteine accessibility method (SCAM), respectively (Davis, Suemitsu and
Wattenberg, 2019). While the topology of the yeast Orm2 and the Arabidopsis ORM1
protein was studied using inserting glycosylation cassettes at specific sites of the protein

12

(Kimberlin et al., 2016). These different approaches confirmed the existence of four
transmembrane domains with the amino- and carboxy- termini facing the cytosol.
1.1.6 Degradation of ORM proteins
An additional mechanism for the regulation of SPT activity is the increased
turnover of ORM proteins. In mammalian cells, the imbalance of PM lipid composition
generated by adding exogenous cholesterol induced degradation of ORMDL1 protein,
through autophagy, and resulted in increased SPT activity without changes in the levels of
SPT subunits (Wang et al., 2015). In yeast, a selective degradation of Orm2 by a novel
route was shown to contribute to sphingolipid homeostasis. The phosphorylation of Orm2
via the TORC2-dependent Ypk1 kinase triggers its export from the ER to the Golgi. Once
on Golgi and endosomes, Orm2 is poly-ubiquitinated by the ubiquitin ligase complex
(Dsc). Then Cdc48/VCP extracts ubiquitinated Orm2 from membranes for proteasomal
degradation (Schmidt et al., 2019). This novel degradation pathway by EGAD (endosome
and Golgi-associated degradation pathway) prevents the accumulation of Orm2 at the ER
and promotes the controlled de-repression of sphingolipid biosynthesis. Interestingly,
although Orm1 shares 72% amino acid identity with Orm2, this protein was not target of
the Dsc complex for degradation.
Regulation of sphingolipids biosynthesis is crucial for growth and to respond to
environmental stimuli. Several exciting discoveries have been made in this area of research
in the last decade, however, many questions remain unanswered. For example, the
mechanisms behind the SPT regulation by ORM proteins in multicellular eukaryotes
remain unclear. While in the yeast model the post-translational modifications are essential
for sensing and responding to sphingolipid availability, in plants and mammals the
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allosteric regulation and protein-protein interactions appear to be the governing
mechanisms. Although the yeast Orm double knockout has been characterized, the lack of
a complete knockout in plants limits the study of the physiological implications of an
unregulated sphingolipid biosynthesis in multicellular eukaryotes. In Chapter 2 of this
thesis we show ORM1 and ORM2 are essential for life cycle completion in Arabidopsis.
orm1−/− orm2−/− seeds were nonviable, accumulated ceramide levels, displayed aberrant
embryo development, and had >80% reduced oil content versus wild-type seeds. This
phenotype was mimicked in Arabidopsis seeds expressing the SPT subunit LCB1 lacking
its first transmembrane domain, which is critical for ORM-mediated regulation of SPT. In
Chapter 3, we provide some insights about the regulatory interaction of ORM proteins with
the LCB1 subunit of SPT. This was possible by the characterization of the orm1∆met/∆met
orm2−/− mutant, which expresses an ORM1 structural variant that is strongly compromised
in the regulation of SPT activity. These plants that did not advance beyond the seedling
stage and hyperaccumulated ceramides and other sphingolipids.
In addition, despite the compelling evidence of the functional redundancy of ORM
isoforms in yeast, mammals and plants; recent reports point to potential individual roles
and distinct regulation of each ORM isoform (Dang et al., 2017; Schmidt et al., 2019). In
Chapter 2 we also uncovered phenotypical growth differences of orm1+/− orm2−/− and
orm1−/− orm2+/− mutants that provide insights into potential differential roles of ORM1 and
ORM2 in plant development. This area of study remains unexplored in the context of
sphingolipid biosynthesis and other physiological processes.
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1.2

Deoxysphingolipids
Sphingolipid metabolism has been extensively studied in humans due to the

association of mutations in genes encoding enzymes of the sphingolipid pathway to
diseases (Hannun and Obeid, 2018; Dunn et al., 2019). One example is the rare condition
Hereditary Sensory and Autonomic Neuropathy type 1 (HSAN1) that has been associated
the production of deoxysphingolipids (Penno et al., 2010). Deoxysphingolipids are
atypical sphingolipids that are generated when SPT utilizes alanine or glycine instead of
serine. As mentioned before, in the sphingolipid biosynthesis pathway, the formation of
the canonical LCB sphinganine (d18:0) requires the condensation of palmitoyl-CoA with
L-serine. Instead, the use of L-alanine gives rise to 1-deoxysphinganine (1-deoxySA;
m18:0) and glycine results in the formation of 1-deoxymethylsphinganine (1deoxymethylSA; m17:0) (Lone et al., 2019) (Figure 1.3).

Figure 1.3 Chemical structures of deoxyLCBs.
Shown are the LCB sphinganine (d18:0) and the deoxyLCBs 1-deoxysphinganine (1-deoxySA; m18:0) and
1-deoxymethylsphinganine (1-deoxymethylSA; m17:0). The position of double bonds in plant deoxyLCBs
is not known.

These LCBs, and the compounds derived from them, are called 1deoxysphingolipids due to the lack of the hydroxyl group at C1 position which prevents
the addition of a polar head group to the ceramide backbone to generate more complex
sphingolipids which are the major forms in which LCBs occur in the cell. In addition, it is
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important to note that the lack of the 1-hydroxyl group in these compounds precludes
their canonical catabolism through the generation of LCB-1-phosphates.
In the last decade, great progress has been made understanding the metabolism
and effects of deoxysphingolipids in the context of the HSAN1 condition in humans.
However, even though these lipids have been also found in fungal species and marine
organisms such as Spisula polynyma (Cuadros et al., 2000), they remain largely
unexplored in plants. In this section we present some of the advances understanding the
synthesis and cellular effects of deoxysphingolipids in mammalian cells and yeast.
1.2.1

HSAN1 Mutations are Related to the Synthesis of Deoxysphingolipids

Even though wild-type SPT can generate deoxyLCBs, missense mutations in the SPTLC1
and SPTLC2 subunits have been linked to increased levels of deoxysphingolipids in the
context of HSAN1 (Penno et al., 2010; Zitomer et al., 2009). Some of the most frequent
mutations found in patients are SPTLC1 C133W, C133Y, S331F, S331F and SPTLC2
A182P, G382V, S384F, I504F (Bode et al., 2015); the analysis of structural models
suggests these mutations induce a shift in the substrate specificity of SPT, from L-serine
to L-alanine or glycine which leads to the formation of the two 1-deoxyLCBs (Penno et
al., 2010; Bode et al., 2015). In contrast, other mutations localized to the surface of the
protein (SPTLC1-S331Y and SPTLC2-I505F) are associated with a severe HSAN1
phenotype and could be involved in protein-protein interactions favoring the production
of these atypical sphingolipids (Rotthier et al., 2010).
For ceramide formation, the N-acylation of LCBs and fatty acyl-CoAs of different
chain length is defined by the ceramide synthase substrate preference. There is also a
distinction in the N-acyl chain distribution of deoxyceramides. In mouse fibroblasts,

16

supplementation with m18:0 revealed this LCB was incorporated to a variety of acylCoAs from C16 to C24:1; while m18:1 was preferentially acylated to VLCFA (Alecu et
al., 2017). However, in contrast to the typical ceramides where the ∆4-desaturase
(DEGS1) introduces a trans double bond at ∆4 position, in the deoxyceramides the
double bond is at position ∆14, and the desaturase has not been identified (Steiner et al.,
2016).

Figure 1.4 Chemical structures of ceramides.
Ceramides are formed by the condensation of a LCB and a fatty acyl-CoA through ceramide synthase. (A)
Hydroxyceramide composed of the LCB t18:1 ∆8 trans and the fatty acid 24:1ω9cis hydroxylated at C-2
position. (B) Non-hydroxylated deoxyceramide composed of the LCB m18:0 and the fatty acid 16:0.

1.3

Cellular Effects of Deoxysphingolipids
Even though the underlying mechanisms behind the HSAN1 condition are not

fully understood, the toxic effects on the neurons and other cells have been attributed to
the accumulation of deoxysphingolipids. Some of the effects include altered Ca2+ levels
related to changes in mitochondria and ER morphology (Alecu et al., 2017); disassembly
of actin fibers and other changes in cytoskeletal structures and (Cuadros et al., 2000),
changes in the physicochemical properties of membranes (Jiménez-Rojo et al., 2014).
In mammalian cells, the accumulation of canonical ceramides, either by de novo
synthesis or hydrolysis of complex sphingolipids, activates apoptosis (Bartke and
Hannun, 2009). In addition to the activation of signaling pathways, another way the
accumulation of ceramides may impact cell processes is by alterations in the biophysical
properties of membranes. Saturated ceramides increase the order of the fluid membranes
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and tend to form gel domains; while ceramides with VLCFA promote the formation of
interdigitated phases (Pinto et al., 2011). In contrast to canonical sphingolipids, the lack
of the hydroxyl group in position 1 make deoxyceramides more hydrophobic and limits
their capacity to form hydrogen bonds with other membrane lipids. This results in poor
miscibility with other membrane lipids, aggregation and a great influence in cellular
membranes, especially the ER membrane in which these lipids are synthesized. Studies
on giant unilamellar vesicles (GUVs) made with a mixture of sphingomyelin and
deoxyceramides revealed that these lipids induce gel-fluid phase separation and are able
to induce the vesiculation of these GUVs (Jimenez-Rojo et al., 2014). It is important to
note that the impact on membrane integrity is also dependent on the abundance of these
compounds. Interestingly, Jimenez-Rojo et al. (2014) found comparable amounts of 1deoxyDHCers and ceramides in a murine macrophage cell line under normal conditions.
1.3.1

HSAN1-like Mutations Affect SPT Activity
Analysis of HSAN1 patients revealed the two most frequent mutations correspond

to SPTLC1 at Cys133 (C133W or C133Y) and Val144 (V144D), these residues are in a
highly conserved region of LCB1 that is predicted to be a catalytic domain. Gable et al.
(2001) found that the corresponding mutations (C180W, C180Y, and V191D) in the
LCB1 gene of Saccharomyces cerevisiae reduced SPT activity by 50 % and increased the
levels of 1-deoxySA. Similarly, HSAN1-associated mutations were shown to confer
dominant negative effects on the SPT activity in lymphoblasts even though the protein
levels of LCB1 and LCB2 subunits did not change (Bejaoui et al., 2002). Reduced SPT
activity was also observed in transgenic mice expressing the LCB1C133W allele
(McCampbell et al., 2005), however, even though the composition of the ceramide pool
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was altered, the total ceramide levels in these mice were unaffected. This suggests the
activation of alternative mechanism to regulate ceramide degradation or the conversion to
glycosylated sphingolipids. Interestingly, using a metabolic labeling approach the
mutations in SPTLC1S331F/Y and SPTLC2I504F resulted in increased SPT activity when
expressed in HEK293 cells, and the rest of the seventeenth analyzed mutations did not
induce any change in activity. However, under FB1 treatment eleven mutations induced a
reduction in SPT activity (Bode et al., 2015).
1.3.2

Degradation of Deoxysphingolipids
1-deoxyspingolipids lack the hydroxyl group at C1 which prevents the addition of

a polar head group to the ceramide backbone to generate more complex sphingolipids. In
addition, the lack of this hydroxyl group also blocks the phosphorylation of LCBs
affecting the canonical degradation pathway by the enzyme LCB lyase that uses
phosphorylated LCBs to generate phosphoethanolamine and hexadecenal, the breakdown
products of sphingolipid catabolism.
The accumulation of 1-deoxysphingolipids has been used a strategy in yeast to
indirectly measure the activity of SPT under the assumption that these structures
accumulate and are not degraded. However, a recent report showed the reduction of
intracellular concentration of 1-deoxysphingolipids over time suggesting alternative
degradation/elimination pathways. 1-deoxysphingosine (m18:1) was metabolized to a
variety of hydroxylated downstream metabolites that appeared to be formed by
cytochrome P450 enzymes (Alecu et al., 2017). Compared to the catabolism of the
canonical LCBs that takes place in minutes to hours, the conversion of the newly
identified metabolites is slower and can take up to several days (Alecu et al., 2017).
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In Chapter 4, we describe that the incorporation of HSNA1-like mutations into
Arabidopsis resulted in early senescence and resistance to the cell death triggered by the
mycotoxin Fumonisin B1.
1.4

Metabolic Modeling
Computational systems biology has emerged as a field to describe biological

networks using mathematical models. Mathematical modeling allows to describe the
behavior of complex biological systems characterized by a substantial larger number of
parameters for predicting cellular phenotypes (Kim, Rocha and Maia, 2018). Some
applications include the design of microbial strains for overproduction of metabolites of
industrial interest. The process of model building is iterative, combining experimental
testing for validation and in silico analysis for optimization (Gadkar, Gunawan and
Doyle, 2005). A model can accelerate the process of hypothesis generation and testing by
predicting plausible regulatory mechanisms that satisfy the observed experimental
behavior of the system under different growth conditions. It can also allow the simulation
of acute perturbations that are normally not amenable to try with experimentation.
Depending on the specific applications, mathematical models vary in their
formulation and complexity. The two main categories of mathematical modeling applied
to metabolism are: steady state and kinetic (Islam and Saha, 2018).
Flux balance analysis (FBA) is in the category of steady-state modeling and relies
on genome-scale metabolic models and the stoichiometry of the metabolic networks to
predict the optimal flux distribution and the impact of perturbations (e.g. gene knockout/overexpression) (Varma and Palsson, 1994). This approach allows the quantitative
interpretation of the metabolic physiology to provide a method for the design and
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optimization of bioprocesses. However, steady-state/stoichiometric models do not capture
essential information like metabolite concentration, enzyme kinetics and regulatory
processes.
Meanwhile, the use of dynamic models including metabolic and regulatory
processes through kinetic expressions (rate equations of enzyme reactions), increases the
accuracy of the phenotype predictions in terms of the temporal behavior of the metabolic
network (Zielinski and Rohwer, 2012). However, practical applications of this approach
are often not feasible due to the lack of defined enzyme kinetic parameters for all
enzymes in the network.
To overcome this limitation, ensemble kinetic modeling (EM) (Tran, Rizk and
Liao, 2008) was developed to build accurate predictive models by sampling through the
entire allowable kinetic solution space. A strategy to reduce the allowable solution space
that needs to be spanned is enforcing thermodynamic feasibility constraints on the
metabolic reactions (Henry, Broadbelt and Hatzimanikatis, 2007; Tran, Rizk and Liao,
2008). The model is then filtered using measured parameters of the system’s response to
different genetic perturbations (Rizk and Liao, 2009). In addition, EM can be used to
predict regulatory interactions occurring in biochemical pathways (Khazaei, McGuigan
and Mahadevan, 2012).
Most of the metabolic modeling for biotechnological purposes has been done in
prokaryotes. Some reasons for the scarcity of eukaryotic models are derived from the
complexity of these organisms in terms of subcellular localization of
proteins/metabolites, intra and extra cellular transporters, limited knowledge of gene
annotation, interactions with different tissues/organs.
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1.4.1

Modeling Sphingolipid Metabolism
Currently, only few models of sphingolipid metabolism are available in the

literature. In part, this is due to the challenges given by the diversity in sphingolipid
composition and the complexity of the numerous interconnected reactions that happen in
various subcellular compartments. A mathematic model of the sphingolipid biosynthesis
was first reported in yeast. This model allowed simulations of metabolic fluxes, included
the connection with phospholipid metabolism and was able to predict outcomes when
enzyme where deleted (Alvarez-Vasquez et al., 2005). A second study in yeast developed
a comprehensive kinetic model which can predict changes in enzyme activity based on
changes in metabolic concentrations that result from genetic perturbations. This model
included pathways for the synthesis of fatty acids to determine potential genes that
impact the distribution of sphingolipid species (Savoglidis et al., 2016). Beyond yeast,
(Gupta et al., 2011) proposed a model including data from lipidomic and transcriptomic
analyses to describe the sphingolipid pathway in mammalian cells. In addition, a recent
study described a model of sphingolipid metabolism in human tissue that simulates the
molecular scenarios in the context of Alzheimer disease including different subcellular
compartments (Wronowska et al., 2015).
It is important to note how various regulatory processes, at the transcriptional and
protein levels are important for the homeostasis of the sphingolipid synthesis. The
previously reported sphingolipid models did not consider regulatory parameters in the
kinetic models or assumed a defined regulatory network. The inclusion of the regulation
schemes by ORMs and other proteins in the models can have an impact on the analysis of
the network response and thus can lead to different conclusions and hypotheses.
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Previous efforts on modeling the sphingolipid pathway have used Saccharomyces
cerevisiae and mammalian cells, however, there are no models based on data from plant
sphingolipid metabolism. It is important to note that the sphingolipid levels typically
reported in the literature correspond to steady state measurements, the result of the
synthesis and turnover of metabolites that cannot be distinguished with the analytical
tools. In Chapter 5, we provide some advances towards building a sphingolipid kinetic
model with measurements derived from metabolic labeling. It is then intent of such
model to provide a basis for understanding synthesis and turnover of sphingolipids in the
context of cellular responses during pathogen infection.
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Chapter 2 Unregulated Sphingolipid Biosynthesis in Gene-Edited Arabidopsis
ORM Mutants Results in Nonviable Seeds.

The content of this chapter has been published.
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E. Markham, Rebecca E. Cahoon, Teresa M. Dunn, Edgar B. Cahoon. Unregulated
Sphingolipid Biosynthesis in Gene-Edited Arabidopsis ORM Mutants Results in
Nonviable Seeds with Strongly Reduced Oil Content. The Plant Cell Aug
2020, 32 (8) 2474-2490; DOI: 10.1105/tpc.20.00015.
2.1

Abstract

Orosomucoid-like proteins (ORMs) interact with serine palmitoyltransferase (SPT) to
negatively regulate sphingolipid biosynthesis, a reversible process critical for balancing
the intracellular sphingolipid levels needed for growth and programmed cell death. Here,
we show that ORM1 and ORM2 are essential for life cycle completion in Arabidopsis
(Arabidopsis thaliana). Seeds from orm1−/− orm2−/− mutants, generated by crossing
CRISPR/Cas9 knockout mutants for each gene, accumulated high levels of ceramides,
indicative of unregulated sphingolipid biosynthesis. orm1−/− orm2−/− seeds were nonviable,
displayed aberrant embryo development, and had >80% reduced oil content versus wildtype seeds. This phenotype was mimicked in Arabidopsis seeds expressing the SPT
subunit LCB1 lacking its first transmembrane domain, which is critical for ORMmediated regulation of SPT. In this study we also uncovered phenotypical growth
differences of orm1+/− orm2−/− and orm1−/− orm2+/− mutants that provide insights into
potential different roles of ORM1 and ORM2 in plant development.
2.2

Introduction
Sphingolipids are essential and abundant endomembrane and plasma membrane

lipids that contribute to membrane function, vesicular trafficking, and mediation of
cellular processes in eukaryotes (Coursol et al., 2003; Liang et al., 2003; Chen et al.,
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2006; Markham et al., 2011). Serine palmitoyltransferase (SPT), the first step in
sphingolipid biosynthesis, is highly regulated in eukaryotes to modulate the requirement
of sphingolipids for growth and membrane function, while limiting accumulation of
LCBs and ceramides until needed to trigger specific cellular functions, such as PCDmediated pathogen defense in plants (Peer et al., 2010). SPT is comprised of LCB1 and
LCB2 subunits and the accessory protein known as small subunit of SPT (ssSPT) or
TSC3 in Saccharomyces cerevisiae (S. cerevisiae) (Gable et al., 2000; Kimberlin et al.,
2013). SPT is primarily regulated by post-translational mechanisms in order to rapidly
respond to perturbations in intracellular sphingolipid concentrations. ORMs or
orosomucoid-like proteins (or ORMDL in mammals) are now recognized as non-catalytic
proteins that negatively regulate SPT (Breslow et al., 2010; Han et al., 2010). In S.
cerevisiae, Orm1p and Orm2p suppress SPT activity in response to elevated sphingolipid
levels through physical interaction that requires the first transmembrane domain of LCB1
(Han et al., 2019). Sphingolipid-responsive regulation of the ORM-SPT interaction in S.
cerevisiae is mediated by phosphorylation/dephosphorylation of the N-terminal domain
of the ORMs (Breslow et al., 2010). This domain is absent from ORM/ORMDL of
higher eukaryotes suggesting alternative regulation of the ORM-SPT interaction, such as
a recently demonstrated mechanism of direct binding of a ceramide molecule to
mammalian ORMDL and yeast ORM to confer negative SPT regulation (Davis et al.,
2019). In addition, ORMDL expression levels vary with sphingolipid availability in
mammalian cells (Gupta et al., 2015).
S. cerevisiae cells are viable after knockout of the two ORM genes, but
accumulate increased amounts of LCBs and ceramides and are sensitive to tunicamycin,
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an inducer of ER stress (Breslow et al., 2010). However, to date, a full understanding of
the biochemical and physiological functions of ORM or ORMDL porteins in multicellular eukaryotes is only beginning to emerge. A recent report showed that ORMDL
proteins are critical for nerve myelination and for suppressing accumulation of toxic
sphingolipid biosynthetic intermediates in mice (Clarke et al., 2019). Studies in
Arabidopsis have previously shown that downregulation of ORM2 using an artificial
miRNA in an ORM1 T-DNA mutant yields fertile plants with increased accumulation of
LCBs and ceramides and early senescence (Li et al., 2016). In addition, RNAi
suppression of Arabidopsis ORM1 and ORM2 resulted in plants with normal appearance
but with increased sensitivity to the ceramide synthase inhibitor fumonisin B1 and
increased LOH2 ceramide synthase activity (Kimberlin et al., 2016). Beyond
Arabidopsis, RNAi of ORM genes in rice was linked to reduced pollen viability
(Chueasiri et al., 2014).
The lack of complete ORM knockout mutants in Arabidopsis or other plants has
precluded assessment of SPT regulation in the absence of ORM proteins. To advance our
understanding of ORM-mediation of sphingolipid biosynthesis we generated
ORM1/ORM2 double mutants using CRISPR/Cas9. Our findings show that in full
ORM1/ORM2 knockout mutants removing sphingolipid biosynthesis regulation results in
nonviable seeds with impaired embryo development, ceramide accumulation and strongly
reduced oil content. We obtained the same phenotypes by removing the first
transmembrane domain of the LCB1 subunit of SPT which is known to be essential for
ORM-SPT interaction.
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2.3
2.3.1

Materials and Methods
Plant Materials and Growth Conditions

Arabidopsis (Arabidopsis thaliana) Columbia-0 (Col-0) was used as the wild-type
reference in this study. Arabidopsis seedlings were grown on Murashige and Skoog (MS)
medium supplemented with 1% (w/v) Sucrose and 0.8% (w/v) agar, pH 5.7, with 16-hlight (100 mmol/ m-2 s-1)/8-h-dark conditions at 22°C. The light source for growth
chamber–grown seedlings was supplied by standard wide-spectrum fluorescent bulbs
type F32/841/ ECO 32 W (maximum intensity, 480 to 570 nm). For Arabidopsis plants in
soil, seeds were sown, and after 2 d of stratification at 4°C, plants were grown at 22°C
with 16-h-light (100 mmol/ m-2 s-1)/8-h-dark conditions.
2.3.2

Generation of CRISPR/Cas9 ORM Mutants

For CRISPR/Cas9-mediated gene editing of ORM1 and ORM2, designed target sites
(Figure 2.1A) were fused with a single guide RNA and expressed under the control of the
U6 promoter. The egg cell–specific EC1 promoter was used to drive Cas9 expression as
previously reported by Wang et al. (2015). In short, BsaI sites were incorporated by PCR
into the ORM target sequences (primers P1 to P4; Supplemental Table 1 in Appendix A).
The purified PCR products were digested with BsaI and ligated to the BsaI-linearized
binary vector pHEE401E. The final CRISPR/Cas9 binary vector was electroporated into
Agrobacterium tumefaciens strain GV3101 and then transformed into the Arabidopsis
Col-0 wild-type plants via the floral dip method (Clough and Bent, 1998). The seeds were
screened for hygromycin resistance on MS plates containing 25 mg/L hygromycin. For
genotyping, fragments including the target regions of ORM1 and ORM2 were amplified
by PCR from the genomic DNA of transgenic plants (primers P5 to P8; Supplemental
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Table 1 in Appendix A). Amplicons were digested with the restriction enzymes BslI
(ORM1) and DraIII (ORM2). The specific indels were identified by DNA sequencing. To
analyze for nontransgenic plants, progeny of hygromycin-selected and confirmed
homozygous (CRISPR/Cas9 mutation) T1 plants were sown directly on soil without
hygromycin selection. These plants were then screened by PCR (P9+P10; Supplemental
Table 1 in Appendix A) for the lack of the Cas9 gene with the presence of the CRISPR
mutation, in the T2 generation. The plants lacking Cas9 but containing the CRISPR
mutation were kept and used for further studies as mutated but not transgenic lines.
2.3.3

Generation of the LCB1∆TMD1 Mutant

LCB1∆TMD1 was generated by deleting coding sequence for 17 amino acids
corresponding to the first transmembrane domain of AtLCB1 (amino acids 35 to 51).
LCB1∆TMD1 under the control of the LCB1 native promoter was cloned into the
pBinGlyRed3 binary vector, which was transformed into A. tumefaciens GV3101 by
electroporation. Heterozygous LCB1/lcb1- knockout mutants (SALK_077745) were
transformed by the floral dip method (Clough and Bent, 1998).
2.3.4

Pollen Staining

Anthers of mature plants were isolated and smeared on a glass slide. The pollen was
stained using Alexander staining method (Alexander, 1969) for 1 h at 25°C. Pollen
imaging was performed using the EVOS FL Auto Cell Imaging System.
2.3.5

Sphingolipid Extraction and Analysis

Sphingolipids were extracted as described in Markham and Jaworski (2007). Briefly,
leaves from 20- to 30-d-old Arabidopsis plants grown on soil were collected and
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lyophilized. Ten to 30 mg of tissue was homogenized and extracted with
isopropanol:heptane:water (55:20:25, v/v/v). We used 1 to 4 mg of plant material for
each biological replicate for sphingolipid analysis from seeds. Internal standards for the
different sphingolipid classes were added. The supernatants were dried and deesterified
with methylamine in ethanol:water (70:30, v/v). The lipid extract was re-suspended in
tetrahydrofuran:methanol:water (5:2:5, v/v/v) containing 0.1% (v/v) formic acid. The
sphingolipid species were analyzed using a Shimadzu Prominence ultra-performance
liquid chromatography system and a 4000 QTRAP mass spectrometer (AB SCIEX). Data
analysis and quantification were performed using the software Analyst 1.5 and
MultiQuant 2.1 as described by Markham and Jaworski (2007), Kimberlin et al. (2013),
and Davis et al. (2020).
2.3.6

Lipid Extraction Analysis

To quantify the TAG content, lipids were extracted from ~1 mg of seeds using a method
based on that of Bligh and Dyer (1959). Seeds were ground using a glass rod in 13x100mm glass screw cap tubes with 3 mL of methanol:chloroform (2:1, v/v).
Triheptadecanoin (17:0-TAG) was added to the seeds as an internal standard prior to
extraction. After 1 h of incubation at 25°C, 1 mL of chloroform and 1.9 mL of water were
added. The solution was mixed thoroughly and centrifuged at 400g for 10 min. The lower
organic phase containing total lipids was transferred to a new glass tube and solvent
evaporated under a N2 stream with heating at 40°C. The sample was redissolved in 1 mL
of heptane and loaded onto a solid phase extraction column (Supelco Supelclean LC-Si
SPE column; Sigma-Aldrich) pre-equilibrated with heptane. A purified TAG fraction was
eluted from the column and converted to fatty acid methyl esters, which were analyzed
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by gas chromatography as previously described (Zhu et al., 2016). TAG fatty acid content
was quantified relative to 17:0 fatty acid methyl ester from the internal standard.
2.3.7

Statistical Analyses

Two-tailed Student’s t test was performed to evaluate statistically significant differences
compared to the control (wild type). One-way ANOVA followed by Tukey’s test was
used to determine the differences among the five genotypes for a given variable. Values
of P < 0.05 were considered statistically significant. The statistical analyses were done
using GraphPad Prism 8.3.0.
2.4
2.4.1

Results
ORMs Are Essential for Plant Development

We designed two single guide RNAs to target regions in the coding sequence of each of
the two Arabidopsis ORM genes (Figure 2.1A). We introduced these constructs into
Arabidopsis via Agrobacterium tumefaciens–mediated transformation to generate
CRISPR/Cas9-induced knockouts of the ORM1 and ORM2 genes. We screened T1 and
T2 transformants by restriction enzyme digestion of the PCR amplicons encompassing
the ORM1 and ORM2 target sites to obtain homozygous lines with mutations in each
gene. These lines were also verified by PCR to lack Cas9 transgenes. These homozygous
single mutants were visually indistinguishable from wild-type plants under optimal
growth conditions (Figure 2.1B).
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Figure 2.1 Gene-edited ORM Arabidopsis mutants.
(A) Schematic representation of CRISPR/Cas9-induced mutations in ORM genes. Gene structures of ORM1
and ORM2; black boxes represent exons. The CRISPR/Cas9 target site is indicated as well as the nucleotide
deletions for each gene in the single mutants. (B) Representative images of 25-d-old wild-type Col-0,
orm1−/−, and orm2−/− plants.

The population of mutants obtained contained nucleotide deletions resulting in
frameshifts and premature stop codons, as determined by PCR–restriction enzyme
digestion and sequencing (Supplemental Figure 1 in Appendix A). To obtain double
knockout mutants, we crossed the orm1−/− and orm2−/− single mutants. No progeny with
homozygous knockout mutations in both genes were obtained after analyzing 155 plants
from the F2 generation and 60 plants from the F3 generation. To gain more insight into
the basis for the apparent lethality associated with the double mutant, we performed
viability staining on pollen from plants genotyped as orm1+/− orm2+/− (Supplemental
Figure 2A in Appendix A). Nearly all of the pollen from these mutants was viable,
similar to pollen from the wild-type plants (Figures 2.2A and 2.2C), rather than 25%
nonviability that would be expected for pollen lethality in this mutant. Instead, a
population of seeds from these plants had dark colored seed coats and were severely
wrinkled. Strikingly, free ceramide concentrations in pooled abnormal seeds were; 40fold higher than those in wild-type seeds and; 8-fold higher than in the normal-appearing
seed segregants from orm1+/− orm2+/− plants (Figure 2.3C).
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Figure 2.2 Pollen Viability and Seed Development from orm1+/− orm2+/− Plants.
(A) Representative images of pollen and anthers (treated with Alexander stain) collected from wild-type
Col-0 and orm1+/− orm2+/− plants. (B) Viability of pollen determined by counts of ~100 pollen grains from
five randomly selected flowers from independent Col-0 and orm1+/− orm2+/− plants. Shown are the mean ±
SD. (C) Developing seeds in siliques from wild-type Col-0 and orm1+/− orm2+/− plants. Shriveled, brown
(abnormal) seeds are indicated by arrows. (D) Percentage of shriveled and brown (abnormal) seeds in
siliques determined by counts of an average of 200 developing seeds from 10 randomly selected siliques of
the independent wild-type Col-0 and orm1+/− orm2+/− plants. Shown are the mean ± SD. Asterisks denote
significant differences as determined by two-tailed Student’s t test, with a significance of P ≤0.01.

This phenotype was observed for 7% of seeds collected from the F2 orm1+/− orm2+/−
plants of orm1−/− and orm2−/− crosses, which is consistent with the expected 6.25%
Mendelian ratio for the occurrence of homozygous double mutants. The remaining seeds
were visually indistinguishable from wild-type seeds (Figures 2.2B and 2.2D). Of the
seeds in these two populations, dark, wrinkled seeds did not germinate, whereas seeds
with normal appearance showed no impairment in germination on solid Sucrosecontaining medium (Figures 2.3A and 2.3B) and soil.
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Figure 2.3 The ORM Double Knockout is Seed Lethal.
(A) Seeds from wild-type Col-0; seeds from orm1+/− orm2+/− were separated and classified into normal and
the darker, shriveled seeds as abnormal. Bars = 1 mm. (B) Phenotypes of 10-d-old seedlings from wild-type
Col-0 seeds and normal and abnormal seeds from orm1+/− orm2+/−. Abnormal seeds did not germinate. (C)
Ceramide content in seeds from wild-type Col-0 and normal and abnormal seeds from orm1+/− orm2+/−.
Shown are the mean ± SD, n 5 3. Asterisks indicate significant differences based on one-way ANOVA
followed by Tukey’s multiple comparisons test, with a significance of *, P ≤0.05 and ***, P ≤0.001.

2.4.2

LCB1-∆TMD1 Mimics the Phenotype of the ORM-null Mutant

We also observed a similar seed phenotype in Atlcb1+/− plants expressing a version of the
LCB1 subunit of SPT lacking its first transmembrane domain (LCB1∆TMD1) that is
required for SPT-ORM regulatory interactions (Han et al., 2019). In these experiments,
the segregating seeds from Atlcb1+/− plants expressing LCB1∆TMD1 included a
population of shrunken, nonviable seeds with a 14-fold increase in ceramide levels
compared with wild-type seeds (Figure 2.4).
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Figure 2.4 Atlcb1+/− Plants Expressing LCB1∆TMD1 Phenocopy the ORM Double Knockout Mutant.
Figure 2.4. (A) Seeds from wild-type Col-0; seeds from Atlcb1+/− plants expressing LCB1∆TMD1 were
separated and classified into normal and abnormal darker and shriveled seeds. Bars = 1 mm. (B)
Phenotypes of 10-d-old seedlings from wild-type Col-0 seeds and normal and abnormal seeds from
Atlcb1+/− expressing LCB1∆TMD1. Abnormal seeds did not germinate. (C) Ceramide content in seeds
from wild-type Col-0 and normal and abnormal seeds from LCB1∆TMD1. Shown are the mean ± SD, n =
3. Asterisks indicate significant difference based on one-way ANOVA followed by Tukey’s multiple
comparisons test, with a significance of **, P ≤ 0.01. NS, not significant.

We examined seeds from the orm1−/− and orm2−/− crosses and LCB1∆TMD1 in more
detail to understand the basis for the loss of viability. The weight of mature nonviable,
abnormal seeds was 80 to 90% lower than that of normal seed segregants from these lines
(Figure 2.5E). Embryos dissected from the abnormal seeds had variable appearance
ranging from cell clusters with undifferentiated appearance to embryo-like structures that
were up to one-third the size of those from normal seeds (Figures 2.5A to 2.5D).
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Underlying this phenotype, oil content of the abnormal seeds, as measured by the fatty
acid content of purified triacylglycerols (TAG), was 85 to 90% lower than that of normal
seed segregants (Figure 2.5F).

Figure 2.5 Abnormal Seeds from ORM and LCB1∆TMD1 Mutant Plants Have Altered Embryo
Morphology and Reduced TAG Concentrations.
(A) to (D) Morphology of embryos from the wild-type seeds (A) and abnormal seeds from orm1+/−
orm2+/−. plants (see [B] to [D]) showing that the embryo is not fully developed. Embryos were dissected
from mature seeds. (E) The 100 seed weight. Values are the mean ± SD of seeds harvested from four
independent plants. Asterisks indicate significant difference based on oneway ANOVA followed by
Tukey’s multiple comparisons test, with a significance of ****, P ≤ 0.0001. NS, not significant; TMD,
transmembrane domain. (F) TAG content in seeds from wild-type Col-0 and normal and abnormal seeds
from orm1+/− orm2+/−. and Atlcb1+/− expressing LCB1∆TMD1. Values are the mean ± SD of three
independent lipid extractions. Asterisks indicate significant difference based on one-way ANOVA followed
by Tukey’s multiple comparisons test, with a significance of ***, P ≤ 0.001 and ****, P ≤ 0.0001. NS, not
significant; TMD, transmembrane domain. (G) Composition of TAG as weight percent of fatty acid in
seeds from wild-type Col-0 and normal and abnormal seeds from orm1+/− orm2+/−. and Atlcb1+/−
expressing LCB1∆TMD1. Values are the mean ± SD of three independent samples. TMD, transmembrane
domain.

The most striking difference in fatty acid composition of TAG from the abnormal seeds
was a reduction in the overall content of C20 and C22 very long chain fatty acids derived
from ER-localized elongation reactions. Notably, the fatty acids 20:2, 20:3, and 22:1
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were not detectable in TAG from the abnormal seeds (Figure 2.5G). Overall, these results
indicate that ORMs are essential for the completion of a full life cycle in Arabidopsis.
Lethality due to the absence of ORM proteins is associated with the recovery of
nonviable seeds with undeveloped embryos that accumulate excessive ceramide
concentrations and have strongly reduced TAG levels. This was phenocopied in plants
with deregulated SPT activity due to the loss of the transmembrane domain of LCB1 that
abolishes ORM regulation of SPT (Han et al., 2019). The identification of nearly the
same phenotype in ORM-null mutants and LCB1-∆TMD1 lines also indicated that the
loss of seed viability is associated with the role of ORM proteins in sphingolipid
metabolism, rather than other reported functions of ORM in Arabidopsis (Yang et al.,
2019).
2.4.3

The orm1+/− orm2−/− and orm1−/− orm2+/− Mutants Have Distinct Growth
Phenotypes

The availability of progeny from orm1−/− and orm2−/− crosses also allowed us to assess
the contributions of each ORM gene to the viability and growth of Arabidopsis plants. In
addition to our inability to obtain homozygous double mutants for these genes, we
observed that orm1−/− orm2+/− mutants were strongly dwarfed and senesced prior to
flowering (Figure 2.6A). By contrast, orm1+/− orm2−/− mutants had a distinct bushy
phenotype with overproliferation of shoots and inflorescences, delayed flowering time
compared to wild-type and an extended life span of 7 months (Figures 2.6B and 2.6C).
The seeds from these plants were viable and rendered 82 % plants genotyped as orm1+/+
orm2−/−, 22 % orm1+/− orm2−/− and 0 % orm1−/− orm2−/−.
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Figure 2.6 orm1+/− orm2−/− and orm1−/− orm2+/− Plants Have Distinct Growth Phenotypes.
(A) Representative image of 35-d-old orm1+/− orm2−/− and orm1−/− orm2+/−plants. The

orm1−/−orm2+/−plants showed reduced size and yellow regions corresponding to cell death. (B)
Representative image of 18-d-old wild-type Col-0 and orm1+/−orm2−/− plants. Mutants showed reduced
size, abnormal leaf shape, and a bushy phenotype. (C) Representative image of 50-d-old orm1+/−orm2−/−
and orm1+/−orm2+/−plants. The orm1+/− orm2−/−plants showed a bushy phonotype and delayed
flowering. (D) Representative image of 80-d-old orm1+/−orm2−/− plant. (E) Representative image of 120d-old orm1+/−orm2−/− plant.

Sphingolipidomic profiling revealed little differences in the concentrations of free LCBs,
the LCB-phosphate (LCB-P) and ceramides among the wild-type, orm1+/− orm2+/−,
orm1−/+ orm2−/− and one plant of the genotype orm1−/−orm2+/−. However, one plant
genotyped orm1−/−orm2+/− (2) showed increased levels of LCBs and ceramides (Fig
2.7A, 2.7B and 2.7C). The ceramide profile of this plant with increased sphingolipid
levels showed accumulation of C16, C22, C24 and C26 ceramides compared to wild type.
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Figure 2.7 LCB and Ceramide Profiles in orm1+/− orm2+/−, orm1+/− orm2−/− and orm1−/− orm2+/−
Plants.
(A) Free LCB composition (d18:0, d18:1, t18:0, t18:1), (B) free LCB-phosphate (LCB-P) and (C) total
ceramide content in two representative plants of each genotype: wild-type Col-0, orm1+/− orm2+/−, orm1+/−
orm2−/−and orm1−/− orm2+/−. (D) and (E) Ceramide molecular species compositions representing the exact
pairings of LCB and fatty acid for the wild-type (D), orm1−/− orm2+/−(E) plants.

2.5

Discussion
Our findings identified the essential role of sphingolipid biosynthetic regulation at

the level of SPT for seed viability, which was previously unclear due to the lack of
complete knockout mutants for ORM genes in plants. We showed that orm1−/− orm2−/−
seeds have impaired embryo development accompanied by hyperaccumulation of the
cytotoxic sphingolipid biosynthetic intermediates ceramides. Strongly enhanced ceramide
accumulation was also observed in the S. cerevisiae orm1∆/orm2∆ mutant (Breslow et
al., 2010; Han et al., 2010) and recently in Ormdl1/3 mutant mice (Clarke et al., 2019).
We also confirmed that impaired seed viability in the mutant is due solely to the function
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of ORMs in SPT regulation, rather than other ascribed ORM functions (Yang et al.,
2019). This was achieved by mimicking this phenotype by removing the first
transmembrane domain of LCB1, which is required for ORM binding to SPT (Han et al.,
2019).
This study emphasizes that the full significance of ORMs to plant viability can
only be assessed by complete knockout of the corresponding genes. By contrast,
Arabidopsis ORM suppressed plants previously generated by RNAi or artificial
microRNA methods were fully viable, although the response to bacterial pathogens was
altered in these plants and early senescence was observed with the most extreme
suppression of ORM expression (Kimberlin et al., 2016; Li et al., 2016). Similar to our
findings, a recent report revealed the inability to recover mice lacking all three ORMDL
genes (Clarke et al., 2019). However, we were able to more precisely determine that
lethality occurs during seed development rather than during gametogenesis. This finding
contrasts with those from previous studies of plants with strongly reduced sphingolipid
biosynthetic capacity due to impaired SPT activity (Dietrich et al., 2008; Teng et al.,
2008; Kimberlin et al., 2013). In these mutants, pollen is defective in endomembrane
formation and is unable to complete maturation. Sphingolipids accumulate to
exceptionally high levels in Arabidopsis pollen relative to leaves (Luttgeharm et al.,
2015b; Ischebeck, 2016). As such, it is likely that pollen is able to tolerate unregulated
sphingolipid synthesis that results from complete ORM knockout.
The use of gene editing also allowed us to assess the redundancy of ORM1 and
ORM2. Notably, single mutants and progeny from the crosses that genotype as orm1+/−
orm2+/− had an appearance similar to the wild-type plants under normal conditions.
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However, orm1−/− orm2+/− seedlings displayed early senescence and did not flower.
Sphingolipid analyses revealed increased ceramides and LCBs levels in one of the plants
of this genotype (Figure 2.7). Consistent with previous reports and our findings (Chapter
3), the accumulation of ceramides likely triggers enhanced expression of PCD-related
genes. It is possible that the differences in sphingolipids content within the biological
replicates was due to sample variation in terms of temporal PCD elicitation.
By comparison, orm1+/− orm2−/− plants were fertile but had a highly bushed
appearance, were strongly delayed in flowering (>80 d to flowering) and had a prolonged
life span of ~7 months. Despite the phenotypic differences no changes were seen in the
levels of sphingolipids in the orm1+/− orm2−/− mutants compared to wild type. It is
important to note that the sphingolipid measurements were performed using leaves,
perhaps significant changes in sphingolipid concentrations can be detected in specific
cells like axillary buds that are groups of meristematic cells located in the leaf axis.
The normal appearance of mutants genotyped as ORM1/orm2−/− and orm1−/−/ORM2
suggests that ORM1 and ORM2 are functionally redundant, despite the phenotypic
differences observed in orm1−/− orm2+/− and orm1+/− orm2−/− seedlings. However, it is
possible that ORM1 and ORM2 have specific roles allowing a fine tuning of SPT activity
through different mechanisms under specific physiological demands. Our studies indicate
that ORM1 may be a more potent inhibitor of SPT or perhaps the stronger phenotype
associated with the complete ORM1 knockout in the ORM2 heterozygous background
reflects the finding that ORM1 is more highly expressed than ORM2 throughout the plant
except in pollen (Kimberlin et al., 2016). The phenotype of the orm1+/− orm2−/− mutant
suggests that ORM2 could contribute to the prolonged life cycle of an Arabidopsis plant
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perhaps by cell type-specific function to fine-tune sphingolipid levels or through a
nonsphingolipid-related function. It has been shown that mutations that lead to prolonged
shoot apical meristems (SAM) activity, continuous generation of new shoots and arrest
senescence of tissues are associated with extended longevity of Arabidopsis (Gan, 2003;
Nooden and Penney, 2001). Moreover, in future work we will determine changes in
phytohormones levels in the mutants. The roles of the hormones auxin and cytokinins are
essential for apical dominance and the suppression of axillary buds (Guo and Gan, 2011).
In this context it is possible that ORM2 has a functional role at the meristematic cells
related to the transport of phytohormones.
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Chapter 3. Compromised regulation of SPT activity leads to hyperaccumulation
of selected sphingolipids, altered organellar structures and transcriptional
regulation.

The content included in this chapter has been published.
Ariadna Gonzalez-Solis, Gongshe Han, Lu Gan, Yunfeng Li, Jonathan
E. Markham, Rebecca E. Cahoon, Teresa M. Dunn, Edgar B. Cahoon. Unregulated
Sphingolipid Biosynthesis in Gene-Edited Arabidopsis ORM Mutants Results in
Nonviable Seeds with Strongly Reduced Oil Content. The Plant Cell Aug
2020, 32 (8) 2474-2490; DOI: 10.1105/tpc.20.00015.
3.1

Abstract

Serine palmitoyltransferase, the first enzyme of sphingolipid biosynthesis, is negatively
regulated by ORM proteins. However, in multicellular eukaryotes the mechanisms of this
regulation are not fully understood, especially the details of the SPT-ORMs interaction
are not known. In this study, through gene editing, we recovered the orm1∆met/∆met
orm2−/− mutant, which expresses an ORM1 structural variant lacking one amino acid
(Met-51). This mutant did not advance beyond the seedling stage, hyperaccumulated
ceramides, and showed altered organellar structures and increased senescence- and
pathogenesis-related gene expression. These seedlings also showed upregulated
expression of genes for sphingolipid catabolic enzymes, pointing to additional
mechanisms for maintaining sphingolipid homeostasis. Moreover, ORM1 lacking Met-51
had strongly impaired interactions with LCB1 in a yeast (Saccharomyces cerevisiae) model,
providing structural clues about regulatory interactions between ORM and SPT.
3.2

Introduction

Sphingolipids have been recognized as abundant membrane components that play several
roles in plant cells. Besides their importance in endomembrane trafficking and formation
of plasma membrane domains, sphingolipids are also bioactive molecules that participate
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in signaling pathways during the pathogen-induced hypersensitive response, abiotic stress
and ABA-dependent guard cell closure (Coursol et al., 2003; Magnin-Robert et al.,
2015). Therefore, the study of sphingolipid metabolism has become an active are of
research in the last decades, especially the emphasis on the regulatory processes that
ensure homeostasis during cell development and responses to the environment. As the
first step in the pathway, serine palmitoyltransferase (SPT) is considered a target for
regulation. Small subunits of SPT (ssSPT) interact with the core subunits of SPT, LCB1
and LCB2, and have an activating effect on the activity (Kimberlin et al., 2013).
Whereas, ORM proteins are negative regulators. Studies of yeast mutants have shown
ORMs are downstream of a Torc2/Ypk1 kinase signaling pathway that senses
sphingolipid availability and regulates SPT activity accordingly (Roelants et al., 2011). In
the yeast regulatory scenario, under sphingolipid depletion ORMs get phosphorylated
relieving SPT inhibition. However, in multicellular eukaryotes, the lack of the N-terminal
domain containing the phosphorylation sites suggests the regulation of SPT by ORMs
occurs through different mechanisms that have not been fully elucidated. Here, we
describe an Arabidopsis mutant expressing an ORM1 structural variant that is strongly
compromised in the regulation of SPT activity. This mutant provided valuable insights
into changes in sphingolipid levels and the effects in the cell. These effects included
compromised organellar structures, the induction of catabolic genes to maintain
sphingolipid homeostasis and pathogenesis-related genes. In addition, this mutant
provided clues about the structural requirements of ORMs for interaction with LCB1 for
the regulation of SPT activity.
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3.3
3.3.1

Materials and Methods
Plant Materials and Growth Conditions

Arabidopsis (Arabidopsis thaliana) Columbia-0 (Col-0) was used as the wild-type
reference in this study. Arabidopsis seedlings were grown on Murashige and Skoog (MS)
medium supplemented with 1% (w/v) Sucrose and 0.8% (w/v) agar, pH 5.7, with 16-hlight (100 mmol/ m-2 s-1)/8-h-dark conditions at 22°C. The light source for growth
chamber–grown seedlings was supplied by standard wide-spectrum fluorescent bulbs
type F32/841/ ECO 32 W (maximum intensity, 480 to 570 nm). For Arabidopsis plants in
soil, seeds were sown, and after 2 d of stratification at 4°C, plants were grown at 22°C
with 16-h-light (100 mmol/ m-2 s-1)/8-h-dark conditions.
3.3.2

Generation of CRISPR/Cas9 ORM Mutants

For CRISPR/Cas9-mediated gene editing of ORM1 and ORM2, designed target sites (Fig
2.1A) were fused with a single guide RNA and expressed under the control of the U6
promoter. The egg cell–specific EC1 promoter was used to drive Cas9 expression as
previously reported by Wang et al. (2015). In short, BsaI sites were incorporated by PCR
into the ORM target sequences (primers P1 to P4; Supplemental Table 1 in Appendix A).
The purified PCR products were digested with BsaI and ligated to the BsaI-linearized
binary vector pHEE401E. The final CRISPR/Cas9 binary vector was electroporated into
Agrobacterium tumefaciens strain GV3101 and then transformed into the Arabidopsis
Col-0 wild-type plants via the floral dip method (Clough and Bent, 1998). The seeds were
screened for hygromycin resistance on MS plates containing 25 mg/L hygromycin. For
genotyping, fragments including the target regions of ORM1 and ORM2 were amplified
by PCR from the genomic DNA of transgenic plants (primers P5 to P8; Supplemental
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Table 1 in Appendix A). Amplicons were digested with the restriction enzymes BslI
(ORM1) and DraIII (ORM2). The specific indels were identified by DNA sequencing. To
analyze for nontransgenic plants, progeny of hygromycin-selected and confirmed
homozygous (CRISPR/Cas9 mutation) T1 plants were sown directly on soil without
hygromycin selection. These plants were then screened by PCR (P9+P10; Supplemental
Table 1 in Appendix A) for the lack of the Cas9 gene with the presence of the CRISPR
mutation, in the T2 generation. The plants lacking Cas9 but containing the CRISPR
mutation were kept and used for further studies as mutated but not transgenic lines.
3.3.3

Genetic Complementation of orm1∆met/∆met orm2−/−

For genetic complementation of the mutant orm1∆met/∆met orm2−/−, ORM1 cDNA was
synthesized with included silent mutations of the ORM1 gRNA target sequence to
mitigate possible editing of the transgene. The cDNA was amplified by overlapping PCR
and cloned into the EcoRI and XbaI sites of binary vector pBinGlyRed3 under the control
of the native ORM1 promoter 600-bp region upstream of the ORM1 start codon (primers
P11 to P16; Supplemental Table 1 in Appendix 1). orm1∆met/∆met orm2−/− plants were
transformed with the pBinGlyRed3-ORM1 construct by the floral dip method (Clough
and Bent, 1998). Transformants were selected based on Discosoma red fluorescent
protein fluorescence and genotyped. Mutation was confirmed by sequencing.
3.3.4

RNA Isolation and Quantitative RT-PCR

RNA was extracted from 12- to 15-d-old Arabidopsis seedlings grown on solid MS
medium. Each replicate corresponds to pooled seedlings from independent plates. RNA
extraction was performed using an RNeasy Kit (Qiagen) according to the manufacturer’s
protocol. The isolated RNA (1mg) was treated with DNase I (Invitrogen). cDNA
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conversion was performed with a RevertAid cDNA synthesis kit (Thermo Fisher
Scientific). SYBR Green was used as the fluorophore in a qPCR supermix (Qiagen).
PP2AA3 and UBIQUITIN (UBQ) were used as internal reference genes. qPCR was
performed using a Bio-Rad MyiQ iCycler qPCR instrument. The thermal cycling
conditions were an initial step of 95°C for 10 min followed by 45 cycles at 95°C for 15 s,
60°C for 30 s, and 72°C for 30 s. Primers used in this study are listed in Supplemental
Table 1 in Appendix 1.
3.3.5

Electron Microscopy

Ten-day-old wild-type and orm1∆met/∆met orm2−/− seedlings were used for TEM. The
samples were cut and fixed with 2.5% (v/v) glutaraldehyde and 2.0% (v/v)
paraformaldehyde in 0.1 M cacodylate buffer. The samples were subjected to postfixation
with 1% (w/v) osmium tetroxide in 0.1 M cacodylate buffer, dehydrated with ethanol and
acetone, and embedded with a Spurr’s Embedding Kit. Ultrathin sections (100 nm) were
cut and stained with uranyl acetate and lead citrate. Samples were imaged on a Hitachi
H7500 transmission electron microscope at an accelerating voltage of 80 kV.
3.3.6

Sphingolipid Extraction and Analysis

Sphingolipids were extracted as described in Markham and Jaworski (2007). Briefly, 12to 15-d-old Arabidopsis seedlings grown on solid medium were collected from
independent plates for each biological replicate. The seedlings were lyophilized, and 10
to 30 mg of tissue was homogenized and extracted with isopropanol:heptane:water
(55:20:25, v/v/v). We used 1 to 4 mg of plant material for each biological replicate for
sphingolipid analysis from seeds. Internal standards for the different sphingolipid classes
were added. The supernatants were dried and deesterified with methylamine in
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ethanol:water (70:30, v/v). The lipid extract was re-suspended in
tetrahydrofuran:methanol:water (5:2:5, v/v/v) containing 0.1% (v/v) formic acid. The
sphingolipid species were analyzed using a Shimadzu Prominence ultra-performance
liquid chromatography system and a 4000 QTRAP mass spectrometer (AB SCIEX). Data
analysis and quantification were performed using the software Analyst 1.5 and
MultiQuant 2.1 as described by Markham and Jaworski (2007), Kimberlin et al. (2013),
and Davis et al. (2020).
3.3.7

Saccharomyces cerevisiae Cell Growth and Expression Plasmids

Saccharomyces cerevisiae strain TDY9113 (Mata tsc3D:NATlcb1D:KAN ura3 leu2 lys2
trp1D) lacking endogenous SPT was used for the expression of Arabidopsis SPT subunits
and ORM proteins as described by Kimberlin et al. (2016). For DoxSA quantification, S.
cerevisiae strain TDY9113 expressing AtLCB1C144W was grown in 1.5% (w/v) Gal and
0.5% (w/v) Glc supplemented with 40 mM Ala. Plasmids for the expression of AtLCB1FLAG, Myc-AtLCB2a, and HA-AtssSPTa in S. cerevisiae were as described by
Kimberlin et al. (2013) and for HA-AtORM1 as described by Kimberlin et al. (2016).
AtLCB1C144W was generated by QuikChange mutagenesis (Agilent Technologies) and
confirmed by sequencing. The open reading frame of AtORM1∆Met51 was amplified by
PCR and inserted into pPR3-N (Dualsystems Biotech) for expression with an N-terminal
HA tag. LCB and DoxSA quantifications were performed as previously described by
Kimberlin et al. (2016).
3.3.8

Immunoprecipitation

Microsomal membrane proteins were prepared from S. cerevisiae cells expressing
FLAG-tagged AtLCB1, Myc-tagged AtLCB2a, HA-tagged AtssSPTa, and HA-tagged
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AtORM1 or AtORM1∆Met51. Microsomal membrane proteins were solubilized in 1.5%
digitonin at 4°C for 2.5 h and incubated with FLAG-beads (Sigma-Aldrich) overnight.
The bound proteins were eluted in immunoprecipitation buffer (50 mM Hepes-KOH, pH
6.8, 150 mM potassium acetate, 2 mM magnesium acetate, 1 mM calcium chloride, and
15% [v/v] glycerol) containing 0.25% (w/v) digitonin and 200 mg/mL FLAG peptide,
resolved on a 4 to 12% (w/v) Bis-Tris NuPAGE gel (Invitrogen), and detected by
immunoblotting with anti-HA (1:5000 dilution; Covance), anti-Myc (1:3000 dilution;
Sigma-Aldrich), and antiFLAG (1:5000 dilution; GenScript) antibodies.
3.3.9

Membrane Topology Mapping of AtORM1∆Met51

AtORM1 or AtORM1∆Met51-encoding synthetic cDNAs with an in-frame glycosylation
cassette (GC) inserted after codon 46, 82 or 121 were synthesized by GenScript and
ligated into pPR3-N for expression with an N-terminal HA tag. The HA-ORM1-GC–
tagged proteins were expressed (along with AtLCB1-FLAG, MYC-AtLCB2a, and HAAtssSPTa) in S. cerevisiae strain TDY9113. Isolation of microsomal proteins, digestion
with endoglycosidase H, and immunodetection of the AtORM1 proteins were performed
as previously described (Kimberlin et al., 2016).
3.3.10 Statistical Analyses
Two-tailed Student’s t test was performed to evaluate statistically significant differences
compared to the control (wild type). One-way ANOVA followed by Tukey’s test was
used to determine the differences among the five genotypes for a given variable. Values
of P ≤ 0.05 were considered statistically significant. The statistical analyses were done
using GraphPad Prism 8.3.0.
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3.4
3.4.1

Results
orm1∆met/∆met orm2−/− Mutant Does Not Survive Beyond the Seedling Stage

Screening of gene-edited lines revealed a mutant with an in frame deletion of a single
codon that resulted in a deletion of the Met residue at amino acid 51 relative to the wildtype ORM1 (Figure 3.1B). This line also carried nucleotide deletions in ORM2 that led to
a frameshift and premature stop codon (Supplemental Figures 1 and 2B in Appendix 1).
Seedlings with the genotype orm1∆met/∆met orm2+/− showed a phenotype like the wild type
and the single mutants under normal growth conditions (Figure 3.1A). However, we
could only recover plants of the genotype orm1∆met/∆met orm2−/− in solid medium
supplemented with Sucrose. The resulting seedlings were severely dwarfed and had a
proliferation of small, deformed chlorotic leaves. These plants persisted in a visually
viable state for 20 to 25 d after planting, but did not progress beyond the seedling stage,
indicating that the orm1∆met/∆met orm2−/− mutation is seedling lethal (Figures 3.1A and
3.1C to 3.1F). Complementation of this mutant with the Arabidopsis ORM1 cDNA under
the control of its native promoter was sufficient to rescue the seedling lethality and
recover fertile plants, although many of the independent complemented mutant lines were
smaller than wild-type plants, which is similar to the phenotype of orm1+/− orm2−/−
plants, as described above (Supplemental Figure 3 in Appendix 1).
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Figure 3.1 orm1∆met/∆met orm2−/− Plants Exhibit Developmental Defects and Do Not Progress beyond
the Seedling Stage.
(A) and (C) to (E) Representative images (A) of the 12-d-old wild-type Col-0, orm1−/−, orm2−/−,
orm1∆met/∆met orm2+/−, and orm1∆met/∆met orm2−/−seedlings. Seedlings with the same phenotype as the wild
type correspond to orm1∆met/∆met orm2+/−; small seedlings showing developmental defects correspond to
orm1∆met/∆met orm2−/−; enlarged images are shown in (C) to (E). Bars = 1 mm. (B) CRISPR/Cas9-induced
mutations in ORM1 and ORM2. Structures of the ORM genes; black boxes represent exons. The position of
the CRISPR target site is marked as well as the nucleotide deletions in each mutant. (F) Phenotypes of 18d-old seedlings; arrows indicate orm1∆met/∆met orm2−/−and asterisk indicates orm1∆met/∆met orm2+/−. Bar = 1
mm.

3.4.2

orm1∆met/∆met orm2−/− Mutant Hyperaccumulates Selected Sphingolipids

Based on the finding that downregulating ORM expression triggers sphingolipid
accumulation (Breslow et al., 2010; Kimberlin et al., 2016; Li et al., 2016), we conducted
extensive sphingolipidomic profiling of our gene-edited mutants from seedlings grown on
Suc medium at 12 to 15 d after planting.
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Figure 3.2 Selected Sphingolipid Classes Highly Accumulate in the orm1∆met/∆met orm2−/− Mutant.
(A) to (G) Total sphingolipid content (A) in wild-type, orm1−/−, orm2−/−, orm1∆met/∆met orm2+/−, and
orm1∆met/∆met orm2−/−. Content of the following sphingolipid classes in the mutants: free LCBs (B), Cer
(Ceramides; see [C]), hCer (hCeramides; see [D]), GlcCer (E), and GIPCs (F). Content of atypical
sphingolipids nh-GlcCer (G) and IPCs (H). (I) Content of atypical deoxyLCB m18:0 in ceramides.
Normally, SPT condenses Ser with palmitoyl-CoA to form d18:0. However, the unusual condensation of
Ala gives rise to a deoxyLCB, DoxSA m18:0. Measurements are the average of four to six replicates
consisting of pooled 12- to 15-d-old seedlings grown on different plates. Bars represent SE of the mean.
Different letters indicate significant difference based on one-way ANOVA followed by Tukey’s multiple
comparisons test (P ≤ 0.05).
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The orm1∆met/∆met orm2−/− mutant accumulated 3.7-fold more sphingolipids than
wild-type seedlings (Figure 3.2A). No significant differences in the levels of free LCBs,
ceramides with nonhydroxylated fatty acids (Cer), or other sphingolipid classes were
detected in the orm1−/−, orm2−/−, or orm1∆met/∆met orm2+/− mutants compared to wild-type
plants (Figures 3.2B to 3.2E and 3.G to 3.2I). In strong contrast, orm1∆met/∆met orm2−/−
seedlings showed heightened accumulation of LCB (5-fold), Cer (90-fold), and ceramides
with hydroxylated fatty acids (hCer; 12-fold) compared to wild-type seedlings of similar
age (Figures 3.2B and 3.2D; Supplemental Figure 4 in Appendix 1). Although no changes
were detected in GlcCer concentrations, the levels of GlcCer containing nonhydroxylated
fatty acids (nhGlcCer), not typically found in abundance in Arabidopsis, were 13-fold
higher in orm1∆met/∆met orm2−/− seedlings than in wildtype seedlings (Figures 6E and 6G;
Supplemental Figures 5 and 6). GIPC levels increased by 48% in the orm1∆met/∆met
orm2−/− mutant compared to wild-type seedlings (Figure 3.2F; Supplemental Figure 7 in
Appendix 1). The LCB composition of the single mutants and orm1∆met/∆met orm2+/− did
not change significantly compared to wild type (Figures 3.3A and 3.3B). However, in
orm1∆met/∆met orm2−/−, the levels of free and phosphorylated forms of d18:0 were the most
strongly increased, with lesser increases in the amounts of t18:0 and t18:1 free and
phosphorylated species (Figures 3.3A and 3.3B). Cer profiles of the single mutants were
similar to those of the wild type (Figures 3.3C to 3.3E). By contrast, the orm1∆met/∆met
orm2+/− mutant had increased amounts of Cer with C16 fatty acids relative to wild-type
and single mutant plants (Figure 3.3F). This phenotype was more accentuated in
orm1∆met/∆met orm2−/− seedlings, which primarily accumulated Cer species with C16 fatty
acids linked to the dihydroxy LCB d18:0 and d18:1 (Figure 3.3G). Increased amounts of
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Cer with C22, C24, and C26 fatty acids as well as atypical C18 and C20 fatty acid–
containing species were also detected in orm1∆met/∆met orm2−/− seedlings relative to wildtype plants and mutants of either ORM gene (Figure 3.3G).

Figure 3.3 Free LCB and Ceramide Compositions and Concentrations Are Strongly Affected in the
orm1∆met/∆met orm2−/− Mutant.
(A) to (G) Free LCB composition (d18:0, d18:1, t18:0, t18:1, [A]) and free LCB-phosphate (LCB-P)
composition in the wild-type, orm1−/−, orm2−/−, orm1∆met/∆met orm2+/−, and orm1∆met/∆met orm2−/−. (B). Bars
show averages of four to six replicates consisting of 12- to 15-d-old pooled seedlings grown on different
plates. Error bars represent the SE of the mean. Different letters indicate significant difference, for each
LCB, based on one-way ANOVA followed by Tukey’s multiple comparisons test (P ≤0.05). Ceramide
molecular species compositions representing the exact pairings of LCB and fatty acid for the wild-type (C),
orm1−/−, (D), orm2−/−, (E), orm1∆met/∆met orm2+/−, (F), and orm1∆met/∆met orm2−/− (G) plants. Measurements
for all panels are the average of four to six replicates consisting of 12- to 15-d-old pooled seedlings grown
on different plates. Bars represent SE of the mean.

Overall, the primary change in the composition of all sphingolipid classes, especially Cer,
hCer, and nhGlcCer, in the orm1∆met/∆met orm2−/− seedlings was the change in the total
and/or relative amounts of those containing C16 fatty acids bound to dihydroxy LCB,
which are derived from the LOH2 ceramide synthase (Figure 3.3G; Supplemental Figures
4 and 6; Markham et al., 2011; Ternes et al., 2011; Luttgeharm et al., 2015a). The
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orm1∆met/∆met orm2−/− plants also contained aberrant forms of hCer and GIPCs with
currently undefined structures based on liquid chromatography–mass spectrometry
ionization as well as Cer with the LCB deoxysphinganine (DoxSA), which is derived
from the condensation of Ala, rather than Ser, to palmitoylCoA by SPT (Figure 6I). In
addition, the concentration of inositolphosphorylceramides (IPCs), the precursors of
GIPCs, increased nearly 12-fold in small orm1∆met/∆met orm2−/− seedlings versus the wild
type (Figure 6H). Overall, these findings are consistent with the notion that SPT
regulation by the ORM1∆met-encoded polypeptide is deficient and that the flux of excess
LCB occurs through the LOH2 ceramide synthase to produce Cer backbones with C16
fatty acids and dihydroxy LCB, a portion of which are channeled to GIPCs but
accumulate as IPC intermediates.
3.4.3

Integrity of Cellular Component Is Compromised in the orm1∆met/∆met orm2−/−
Mutant

Given that sphingolipids are abundant endomembrane and plasma membrane components
that contribute to vesicular trafficking, we used transmission electron microscopy (TEM)
to evaluate the subcellular phenotypes associated with enhanced sphingolipid
accumulation in 10-d-old orm1∆met/∆met orm2−/− seedlings relative to the wild-type
seedlings of the same age. Mesophyll cells from the wild-type seedlings showed large
vacuoles with turgor pressure pushing organelles to the periphery (Figure 3.4A).
Chloroplasts of the wild-type cells had the typical oval shape and well-defined thylakoid
membranes (Figures 3.4A and 3.4B). By contrast, the orm1∆met/∆met orm2−/− mutant cells
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Figure 3.4 Subcellular Features are Strongly Altered in the orm1∆met/∆met orm2−/− Mutant.
(A) to (H) Representative TEM images of the wild-type seedlings (see [A] and [B]) and orm1∆met/∆met
orm2−/−. (see [C] to [I]). Longitudinal sections of leaves from 10-d-old seedlings were prepared for TEM
analysis. Boxes represent sections enlarged in (E) and (H). Asterisks indicate vesicles and arrows
autophagosomes. Bar = 200 nm in (I); bars = 800 nm in (E) and (F); bar = 1mm in (B); bars = 2mm in (A)
and(C); and bars = 4mm in (D) and (G). Ch, Chloroplast; CW, cell wall; GA, Golgi apparatus; M,
mitochondrion; V, vacuole.

displayed a lack of vacuolar turgor (Figure 3.4D). In addition, chloroplasts of
orm1∆met/∆met orm2−/− cells were round and showed marked disintegration of thylakoids
and highly abundant osmiophilic structures that resemble plastoglobuli (Figures 3.4C to
3.4F). Notably, increased vesicle numbers were observed around the ER network in
orm1∆met/∆met orm2−/− cells (Figure 3.4F). Furthermore, electrodense material and double
membrane vesicles consistent with autophagosomes were detected inside the vacuoles of
these cells. Moreover, entire chloroplasts were engulfed and appeared to be in the process
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of degradation (Figures 3.4G and 3.4H). Despite these large defects, Golgi stacks were
detectable in orm1∆met/∆met orm2−/− cells (Figure 3.4I).
3.4.4

Genes for Ceramide Synthases, LCB Kinase, and LCB-Phosphate Lyase Are
Upregulated in the orm1∆met/∆met orm2−/− Mutant

Given the increased concentrations of most sphingolipid classes in orm1∆met/∆met orm2−/−,
we examined the expression of genes in 12-d-old seedlings for key sphingolipid
biosynthetic and catabolic enzymes, including the SPT-associated polypeptides LCB1
and ssSPTa, ceramide synthases (LOH1, LOH2, and LOH3), sphingosine kinases
(SPHK1 and SPHK2), and the LCB catabolic enzyme LCB-phosphate lyase (or DPL1).
No significant differences were detected in the expression of genes for LCB1, ssSPTa, or
LOH1 in any mutant analyzed (Supplemental Figures 8A to 8C in Appendix 1).
However, consistent with the increased amounts of ceramides in orm1∆met/∆met orm2−/−,
the ceramide synthase gene LOH2 showed a 2.5-fold increase in expression and the
ceramide synthase gene LOH3 showed a 2-fold increase in orm1∆met/∆met orm2−/− plants
compared to the wild type and the other mutants examined (Figures 3.5A and 3.5B).
Most notably, the expression of the key sphingolipid catabolism-associated genes SPHK2
and DPL1 increased by approximately six- to sevenfold, respectively, in orm1∆met/∆met
orm2−/− plants relative to the wild type and other ORM mutants (Figures 3.5C and 3.5D).
This result is consistent with the notion that the induction of LCB catabolism is one route
(in addition to ceramide biosynthesis) for the mitigation of unregulated LCB production
in the orm1∆met/∆met orm2−/− mutant.
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Figure 3.5 Expression of Genes Associated with Sphingolipid Homeostasis, Plant Defense Responses,
and Senescence are Upregulated in the orm1∆met/∆met orm2−/− Mutant.
(A) to (H) Wild-type, orm1−/−, orm2−/−, orm1∆met/∆met orm2+/−, and orm1∆met/∆met orm2−/−. seedlings of 12-dold plants were used to examine gene expression by qPCR to monitor genes encoding enzymes in
sphingolipid biosynthetic and catabolic pathways: ceramide synthase gene LOH2 (A), ceramide synthase
gene LOH3 (B), sphingosine kinase 2 gene SPHK2 (C), and LCB-phosphate lyase gene DPL1 (D) and
selected pathogenesis- and senescence-related genes: β-1,3-glucanase gene PR2 (E), class III peroxidase
gene PRXC (F), flavin monooxygenase gene FMO (G), and senescence-related 13 gene SAG13 (H).
PP2AA3 transcript levels were used as a control for the sphingolipid genes and UBQ for the pathogenesisand senescence-related genes. Specific primers used for this analysis are shown in the Supplemental Table
1 in Appendix 1. Gene expression levels are normalized to those in wild-type seedlings. Values are the
mean ± SD (n = 6 to 12). Different letters indicate significant difference based on one-way ANOVA
followed by Tukey’s multiple comparisons test (P ≤ 0.05).

3.4.5

Defense and Senescence Genes Are Upregulated in the orm1∆met/∆met orm2−/−
Mutant

The accumulation of ceramides has been linked to the activation of signaling pathways
that lead to PCD (Liang et al., 2003; Bi et al., 2014). To examine whether the high
amounts of ceramides in orm1∆met/∆met orm2−/− activate PCD, we performed qPCR of
marker genes using RNA extracted from 12-d-old seedlings. The expression of the
pathogenesis-related genes (PR-2, PRXC, FMO, PR3) was significantly higher in
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orm1∆met/∆met orm2−/− than in the wild type and the other mutants (Figures 3.5E to 3.5G;
Supplemental Figure 8E in Appendix 1). A similar expression pattern was also observed
for the senescence-related gene SAG13 (Figure 3.5H).
3.4.6

ORM1∆Met51 Fails to Interact with LCB1 to Suppress SPT Activity

Our results clearly show that ORM1 lacking Met-51 is strongly impaired in repressing
SPT activity. This amino acid is located in the ER luminal domain immediately adjacent
to the second transmembrane domain of ORM1 (Supplemental Figure 9 in Appendix 1).
We hypothesized that, without this amino acid, the conformation of the second
transmembrane domain of ORM1 is altered such that the interaction with LCB1 for the
repression of SPT activity is disrupted.

Figure 3.6 Expression of AtORM1∆Met51 in yeast
(A) AtORM1∆Met51 was stably expressed in S. cerevisiae with the native SPT complex replaced by the
Arabidopsis SPT complex (see Methods). AtLCB1- FLAG, MYC-AtLCB2a, and HA-AtssSPTa without or
with HA-AtORM1 or HA-AtORM1∆Met51were expressed in S. cerevisiae strain lcb1 tsc3. Five, 10, and 15
mg of microsomal proteins was loaded and analyzed by SDS-PAGE (4 to 12%; Invitrogen) and detected
with anti-LCB1 (1:3000) and anti-HA (Covance) antibodies. (B) DoxSA levels were determined from cells
expressing AtLCB1C144W and AtLCB2a, HA-AtssSPTa along with vector, HA-AtORM1 wild-type, or
HAAtORM1∆Met51. Shown are the mean ± SD of DoxSA levels from six independent colonies for each
strain. Asterisks denote significant differences, as determined by two-tailed Student’s t test with a
significance of P ≤ 0.001; NS, not significant, n=6.

To better understand this regulatory mechanism, we stably expressed the Arabidopsis
ORM1∆Met51 mutant protein in an S. cerevisiae mutant background in which AtLCB1,
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AtLCB2, and AtssSPTa replaced the corresponding S. cerevisiae SPT-associated
polypeptides, as confirmed by immunoblotting (Figure 3.6A).
We assessed in vivo SPT activity by measuring the DoxSA produced when expressing
AtLCB1C144W (Figure 3.6B). DeoxyLCBs cannot be phosphorylated/degraded and are
used as a readout for in situ SPT activity (Gable et al., 2010; Kimberlin et al., 2016).
When expressed in this S. cerevisiae background, the wild-type Arabidopsis ORM1 was
able to suppress DoxSA production, which is consistent with its function as a negative
regulator of SPT activity. By contrast, DoxSA concentrations in AtORM1∆Met51expressing cells were similar to those in vector control cells lacking ORM1, which is
consistent with a lack of repressed SPT activity. ORMs interact with the first
transmembrane domain of LCB1 to repress SPT activity in S. cerevisiae (Han et al.,
2019), although the structural components of ORM associated with this interaction have
not been defined. To test whether AtORM1∆Met51 physically interacts with AtLCB1, as
does the wild-type ORM1, we performed coimmunoprecipitation of FLAG-tagged
AtLCB1 with solubilized microsomes from S. cerevisiae cells expressing Myc-AtLCB2a,
hemagglutinin (HA)-AtssSPTa, and HA-AtORM1 or HA-AtORM1∆Met51.
Pull-downs of AtLCB1 resulted in coimmunoprecipitation of AtLCB2a and AtORM1,
but not ELO3, an ER protein that does not interact with SPT. By contrast, only trace
amounts of HA-AtORM1∆Met51 were detected in the AtLCB1 pulldowns (Figure 3.7A).
This finding indicates that Met-51 is critical for the ORM-LCB1 physical interaction to
regulate SPT activity. To determine whether the impaired ORM-LCB1 interaction is due
to gross or subtle alterations in the secondary structure of ORM induced by the Met51
deletion, we compared the membrane topology of AtORM1 and AtORM1∆Met51.
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Figure 3.7 AtORM1∆Met51 Fails to Regulate SPT Activity and Does Not Interact with LCB1.
(A) Coimmunoprecipitation of FLAG-tagged AtLCB1 in S. cerevisiae expressing AtLCB1-FLAG, MYCAtLCB2a, HA-AtssSPTa, and either HA-AtORM1 or HA-AtORM1DMet51. Solubilized S. cerevisiae
microsomes were incubated with anti-FLAG beads, and protein was eluted with FLAG peptide. Solubilized
microsomes (Input), unbound and bound (IP-FLAG) were analyzed by immunoblotting. ELO3, an integral
ER membrane protein, was used as a negative control. (B) Topology mapping of AtORM1DMet51. GCs
were inserted after the indicated amino acids, and the GC-tagged proteins were expressed in S. cerevisiae.
Increased mobility following treatment of microsomes with endoglycosidase H (Endo H) revealed that the
GCs at residues 46 and 121 are glycosylated and therefore reside in the lumen of the ER. However, the GC
at residue 82 is not glycosylated, indicating that residue 82 is located in the cytosol. AtORM1∆Met51 retains
the topology of wild-type (WT) ORM1.

We inserted glycosylation cassettes into the two predicted ER luminal loops (at amino
acids 46 and 121) and into the cytosolic loop between the second and third
transmembrane domains (at amino acid 82) and expressed the proteins in S. cerevisiae
along with reconstituted Arabidopsis SPT. The analysis showed that the cassettes in the
predicted luminal domains were glycosylated, while the cassette in the predicted
cytosolic domain was not (Figure 3.7B). Thus, we conclude that ORM1 with the Met51
deletion retains the topology of wild-type ORM1.
3.5

Discussion

Among the gene-edited ORM variants identified in our studies was a mutant that
contained an in-frame deletion of Met-51 combined with a homozygous knockout of
ORM2 (orm1∆met/∆met orm2−/−). Seeds from this mutant were viable, in contrast to orm1−/−
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orm2−/−; however, the plants did not advance beyond the seedling stage and had strong
developmental defects. Like the orm1−/− orm2−/− seeds, the orm1∆met/∆met orm2−/−
seedlings hyperaccumulated ceramides with C16 fatty acids. These seedlings also
accumulated aberrant sphingolipids including DoxSA containing ceramides, GlcCer
containing nonhydroxylated fatty acids, and IPCs, all of which were nearly absent from
wild-type seedlings. Cells from the orm1∆met/∆met orm2−/− seedlings displayed gross
defects in membrane and organellar structures as well as apparent autophagosome-like
structures. The early cell death displayed by the orm1∆met/∆met orm2−/− seedlings can be
attributed to the activation of PCD pathways, as indicated by the high transcript levels of
pathogenesis- and senescence-related genes that have been shown to be activated by the
accumulation of LCB and ceramides. Notably, Met-51 is predicted to occur at a position
that is adjacent to the second transmembrane domain of ORMs, but is not a conserved
residue across eukaryotic ORM or ORMDL proteins (Supplemental Figure 9 in Appendix
1). Using S. cerevisiae mutants containing the Arabidopsis SPT complex, we determined
that the ORM1 Met51 mutant has greatly reduced interaction with Arabidopsis LCB1,
which is required for ORM-induced suppression of SPT activity. Given that Met-51 is not
conserved in eukaryotes, it is likely that LCB1 does not directly interact with this residue.
Instead, the lack of this amino acid likely produces a conformational change at the second
transmembrane domain of ORM that impedes its regulatory interaction with the first
transmembrane domain of LCB1. The maintenance of the topology of ORM1∆Met51 in
microsomal membranes was verified by endoglycosidase H digestion studies using the
mutant ORM1 protein carrying glycosylation cassettes. To date, no residues or structural
features in ORMs have been identified that are associated with their interaction with the
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LCB1/ LCB2 heterodimer of SPT. Our findings point to the possible interaction of the
first transmembrane domain of LCB1 with the second transmembrane domain of ORM as
the basis for SPT regulation. Additional structural studies are required to fully elucidate
these potential regulatory interactions between ORM and LCB1.
Our results also revealed transcriptional mechanisms for maintaining sphingolipid
homeostasis upon the enhanced production of LCBs in the orm1∆met/∆met orm2−/− mutant.
LOH2 and LOH3 (encoding the functionally distinct ceramide synthases), SPHK2
(enconding a LCB kinase) and DPL1 (encoding the last step in LCB degradation) were
transcriptionally upregulated in the mutant. Notably, upregulating LOH2 expression was
associated with the preponderance of ceramides containing C16 fatty acids and dihydroxy
LCBs (the principal products of LOH2 ceramide synthase activity) in free ceramides and
GlcCer, including nhGlcCer, which accumulated in orm1∆met/∆met orm2−/− seedlings but
were detected at only low concentrations in the wild type and ORM1 and ORM2 single
mutants. These findings are consistent with our previous report that LOH2 activity is
upregulated in Arabidopsis ORM RNAi plants, presumably as a pathway for reducing
cytotoxicity of free LCBs and ceramides (which are metabolized to GlcCer; Kimberlin et
al., 2016). No changes were detected in LCB1 or ssSPTa transcript levels in the
orm1∆met/∆met orm2−/− mutant, indicating that the transcriptional regulation of genes for
SPT complex proteins is not a pathway for maintaining sphingolipid homeostasis in
response to deregulated LCB biosynthesis. Instead, the expression of genes involved in
the catabolism of LCBs increased approximately six- to sevenfold (SPHK2 and DPL1) in
this mutant, suggesting that an unknown mechanism is activated in response to increased
ceramide and/or LCB levels.
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Chapter 4 Investigating the physiological effects of HSAN1-like mutations in
Arabidopsis.

This chapter may be part of a publication in the future.
Authors: Ariadna Gonzalez Solis, Rebecca E. Cahoon, Gongshe Han, Teresa M. Dunn,
Edgar B. Cahoon.
4.1

Abstract
The deoxysphingolipids are atypical sphingolipids that are generated when serine

palmitoyltransferase (SPT) condenses palmitoyl-CoA with alanine or glycine instead of
serine during the synthesis. The shift in substrate specificity is associated with variants of
SPT subunits that have specific point mutations. Even though great progress has been
made understanding the metabolism and effects of deoxysphingolipids in the context of
the hereditary sensory autonomic neuropathy type 1 (HSAN1) in humans, these atypical
sphingolipids remain largely unexplored in plants.
Here we provide insights into the physiological effects in Arabidopsis caused by
the incorporation of the point mutations in SPT that are associated with the accumulation
of deoxysphingolipids. Our research demonstrated that the changes in SPT resulted in
early senescence and resistance to the cell death triggered by the mycotoxin Fumonisin
B1.
4.2

Introduction
Serine palmitoyltransferase (SPT) catalyzes the first reaction of sphingolipid

biosynthesis by condensing L-serine with palmitoyl-CoA to form sphingoid bases or long
chain bases (LCBs), the characteristic backbone of all sphingolipids. The core SPT is a
heterodimer formed by LCB1 and LCB2 subunits, additional regulatory proteins like
ssSPT and ORM proteins interact with the core SPT and have an impact on its activity
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(Tamura et al., 2001; Chen et al., 2006; Dietrich et al., 2008; Kimberlin et al., 2013;
Kimberlin et al., 2016). Based on studies of Saccharomyces cerevisiae it is known that
the active site of SPT is localized at the dimer interface, and LCB1 stabilizes the complex
(Gable et al., 2002). Moreover, several studies in Arabidopsis have shown knock-out
mutants for the LCB2 (LCB2a and LCB2b) and LCB1 genes are not viable, emphasizing
the importance of sphingolipids as essential components of plant cells (Tamura et al.,
2001; Chen et al., 2006; Dietrich et al., 2008).
In humans, eight missense mutations in SPTLC1 and four mutations in the
SPTLC2 subunits (LCB1 and LCB2 ortologues, respectively), are associated with
Hereditary Sensory and Autonomic Neuropathy 1 (HSAN1), a rare dominantly inherited
degenerative disorder caused by the accumulation of unusual deoxysphingolipids (Penno
et al., 2010). All the HSAN1 mutations characterized to date induce a shift in the
substrate specificity of SPT from L-serine to L-alanine or glycine giving rise to 1deoxyshinganine (1-deoxySA; m18:0) or 1-deoxymethylsphinganine (1-deoxymetylSA:
m17:0). These atypical LCBs can get N-acylated by ceramide synthases to form
ceramides; however, the lack of the hydroxyl group in C1 position precludes the
formation of more complex glycosylated sphingolipids. The missing hydroxyl group also
hampers the degradation of deoxyLCBs by the canonical pathway that requires
phosphorylation at C1 to form the catabolic phosphorylated intermediates.
Interestingly, out of the context of HSAN1, 1-deoxysphingolipids were also
detected in a mammalian cell line treated with the ceramide synthase inhibitor Fumonisin
B1 (FB1) (Zitomer et al., 2009). In this study the accumulation of canonical LCBs was
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accompanied with 1-deoxySA suggesting that the wild-type SPT is also capable of using
alanine and glycine as substrates.
The study of SPT regulation requires a robust, sensitive and reproducible method
to measure its activity. In mammalian cells and yeast, SPT activity is usually measured
by a radioactivity-based assay using 3H or 14C-serine as substrate that gets incorporated
into 3-ketosphinganine (Williams et al., 1984). However, measuring the activity in plants
is still problematic due to the low activity in in vitro assays. Evidence in yeast shows the
non-degradable deoxySA could serve as a strategy to measure SPT activity as this LCB
accumulates and is not degraded (Chapter 3) (Gable et al., 2010; Kimberlin et al., 2016).
For this study, we hypothesize that incorporating the HSAN1 mutations into
Arabidopsis SPT would allow the production of deoxysphingolipids, which could be used
as a readout for SPT activity. Moreover, the characterization of transgenic plants
expressing mutations in LCB1 would allow us to examine the physiological effects of the
unusual sphingolipids that until now have not been explored in plants.
Here we describe the incorporation of the mutated versions LCB1C144W and
LCB1C144W V155D into Arabidopsis resulting in early senescence hallmarks. We also
determined that these plants are resistant to the mycotoxin FB1. Although we did not
detect a significant accumulation of deoxyceramides in the transgenic plants compared to
wild type, we observed that m18:0 and m18:1 were incorporated to ceramides containing
C16 fatty acids. Future work will focus on the detection of potential degradation products
of deoxysphingolipids and their subcellular localization.
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4.3
4.3.1

Materials and Methods
Plant Materials and Growth Conditions

Arabidopsis (Arabidopsis thaliana) Columbia-0 (Col-0) was used as the wild-type
reference in this study. Arabidopsis seedlings were grown on Murashige and Skoog (MS)
medium supplemented with 1% (w/v) Sucrose and 0.8% (w/v) agar, pH 5.7, with 16-hlight (100 mmol/ m-2 s-1)/8-h-dark conditions at 22°C. The light source for growth
chamber–grown seedlings was supplied by standard wide-spectrum fluorescent bulbs
type F32/841/ ECO 32 W (maximum intensity, 480 to 570 nm). For Arabidopsis plants in
soil, seeds were sown, and after 2 d of stratification at 4°C, plants were grown at 22°C
with 16-h-light (100 mmol/ m-2 s-1)/8-h-dark conditions.
4.3.2

HSAN1 LCB1 Generation and Transformation

Two versions of the HSAN1 mutations were generated in AtLCB1 using QuikChange
Site-Directed Mutagenesis Kit (Stratagene), LCB1C144W an LCB1C144W V155D. The mutated
versions of LCB1 were then cloned into the vector pBinGlyRed3 under the native LCB1
promoter (~1kb). The Binary vectors were transformed into Agrobacterium tuumefaciens
GV3101 by electroporation. Heterozygous LCB1 mutants (SALK_077745) were used to
create transgenic plants by the floral dip method (Clough and Bent, 1998). Red seeds
were screened using a green LED light and a red2 camara filter to identify transformed
Arabidopsis seeds harboring the vector expressing DsRed.
4.3.3

Arabidopsis Mutant Genotyping

The T-DNA SALK_077745 insertion line was acquired from the Arabidopsis Biological
Resource Center. Individual plants from a mixed population of seeds were screened by
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PCR using the primers P1+P3. The wild-type allele was amplified using P2+P3;
Supplemental Table 1 in Appendix B.
4.3.4

Sphingolipid Extraction and Analysis

Sphingolipids were extracted as described in Markham and Jaworski (2007). Briefly, 35d-old Arabidopsis leaves were collected for biological replicates. The plant tissue was
lyophilized, and 10 to 30 mg of tissue was homogenized and extracted with
isopropanol:heptane:water (55:20:25, v/v/v). Internal standards for the different
sphingolipid classes were added. The supernatants were dried and de-esterified with
methylamine in ethanol:water (70:30, v/v). The lipid extract was re-suspended in
tetrahydrofuran:methanol:water (5:2:5, v/v/v) containing 0.1% (v/v) formic acid. The
sphingolipid species were analyzed using a Shimadzu Prominence ultra-performance
liquid chromatography system and a 4000 QTRAP mass spectrometer (AB SCIEX). Data
analysis and quantification were performed using the software Analyst 1.5 and
MultiQuant 2.1 as described by Markham and Jaworski (2007) and Kimberlin et al.
(2013).
4.3.5

Alanine and Fumonisin B1 Treatment

Selected red seeds were sown on MS medium supplemented with 5 mM Alanine (Acros
Organics) or 0.4 µM Fumonisin B1 (Sigma).
4.3.6

RNA Isolation and Quantitative RT-PCR

RNA was extracted from 12- to 15-d-old Arabidopsis seedlings grown on solid MS
medium. Each replicate corresponds to pooled seedlings from independent plates. RNA
extraction was performed using an RNeasy Kit (Qiagen) according to the manufacturer’s
protocol. The isolated RNA (1mg) was treated with DNase I (Invitrogen). cDNA
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conversion was performed with a RevertAid cDNA synthesis kit (Thermo Fisher
Scientific). SYBR Green was used as the fluorophore in a qPCR supermix (Qiagen).
PP2AA3 was used as internal reference genes. qPCR was performed using a Bio-Rad
MyiQ iCycler qPCR instrument. The thermal cycling conditions were an initial step of
95°C for 10 min followed by 45 cycles at 95°C for 15 s, 60°C for 30 s, and 72°C for 30 s.
Primers used in this study are listed in Supplemental Table 1, Appendix B.
4.4
4.4.1

Results
SPT Amino Acids Associated with HSAN1 are Conserved in Arabidopsis

Two frequent mutations that cause HSAN1 in humans are C133W and V144D. The
human SPTLC1 and Arabidopsis LCB1 share 44 % identity with each other. Based on
the sequence alignment Cysteine 144 in Arabidopsis corresponds to C133 in human
SPTLC1 and it is located in a conserved region (Figure 4.1). Similarly, the Valine residue
in position 155 that corresponds to V144 in human. Mutating the Cysteine to Tryptophan
and Valine to Aspartic acid, should confer the structural shift to allow the use of alanine
and glycine to generate deoxysphingolipids.

Figure 4.1 Partial alignment of Arabidopsis thaliana AtLCB1 and Homo sapiens HsSPTLC1 protein
sequences.
The arrows indicate two residues associated with HSAN1 phenotype, C133 and V144 in human and the
corresponding C144 and V155 in Arabidopsis.
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Given that the complete knockout of LCB1 is lethal (Chen et al., 2006), for this study we
sought to complement the LCB1 heterozygous mutants with a construct expressing
LCB1C144W or LCB1C144W/V155D under the native LCB1 promoter. In a previous work it
was showed that a construct containing the wild-type AtLCB1 under the control of the
upstream native promoter was sufficient to complement the SALK_077745 T-DNA
mutant (Chen et al., 2006). With a successful complementation we would expect the
levels of deoxysphingolipids to accumulate and this could be used as strategy to measure
SPT activity. However, after three and four generations complementation was not
achieved (Tables 1 and 2; Supplemental Figure 1 in Appendix B). Therefore, the rest of
the experiments in this study were performed using transgenic lines expressing the
mutated LCB1 versions in a wild-type or a heterozygous background. Considering that
these mutations are dominant in the context of HSAN1 (Dawkins et al., 2001), we expect
that even with a copy of the wild-type LCB1 the mutated version will still promote the
generation of deoxysphingolipids.
Table 1 Segregation analysis of progeny from LCB1C144W transgenic lines
Parent
genotype

T2
Aa
T3
Aa

Progeny Genotype (Observed/Total)
AA

Aa

aa

19/33
57.6%
56/58
96.6%

14/33
42.4%
2/58
3.4%

0/33
0%
0/58
0%

Table 2 Segregation analysis of progeny from LCB1C144W V155D transgenic lines
Parent
genotype

T2
Aa
T3
Aa
T4
Aa

Progeny Genotype (Observed/Total)
AA

Aa

aa

3/21
14.3%
33/52
63.5%
11/25
44%

18/21
85.7%
19/52
36.5%
14/25
56%

0/21
0%
0/52
0%
0/25
0%
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4.4.2

Arabidopsis HSAN1 Mutants Showed Early Senescence, Delayed Flowering
and Resistance to FB1.

To examine the phenotype of the transgenic lines, seeds were grown in solid MS
medium. Both lines tested showed low germination rates ~26 % when expressing
LCB1C144W and ~ 54 % for LCB1C144W/V155D. Moreover, the transgenic seedlings
developed pale/yellow leaves compared to the wild type (Figure 4.2A). We also observed
pale wild-type seedlings growing on medium supplemented with alanine and a stronger
effect on the transgenic plants (Figure 4.2B).

Figure 4.2 Representative images of 15-day-old wild-type, LCB1C144W and LCB1C144W/V155D seedlings.
(A) MS medium, (B) MS medium supplemented with 5 mM Alanine, and (C) MS medium supplemented
with 0.4 µM FB1.

Interestingly, even though wild-type plants were sensitive to FB1, the seedlings
expressing LCB1 with mutations showed resistance to the toxin but still showed pale-
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yellow leaves (Figure 4.2C). When transferred to soil the transgenic plants recovered the
green appearance but showed delayed flowering and early senescence features (Figure
4.3 A and Supplemental Figure 1 in Appendix B).
Chlorotic and green leaves were used for sphingolipid extractions to measure the
canonical species and deoxyceramides. Sphingolipid profiling revealed that, even though
there was not a significant change in the levels of m18:0 and m18:1-containing ceramides
compared to wild type these deoxyLCBs were preferentially coupled with C16 fatty acids
(Figure 4.3B). In addition, the chlorotic leaves accumulated C16 fatty acid containingceramides compared to the normal green leaves (Figure 4.3C).

Figure 4.3 Ceramides and Deoxyceramides Profiles.
(A) Forty-day old wild-type plants and transgenic lines expressing LCB1C144W and LCB1C144W/V155D.
Ceramide molecular species compositions representing the exact pairings of LCB and fatty acid for the
wild-type and the indicated transgenic lines in (B) green leaves and in (C) yellow/pale leaves. Shown are
representative values of one plant or the mean ± SD n=3.
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4.4.3

Expression of Genes Associated with Senescence and Sphingolipid
Biosynthesis and Homeostasis

Figure 4.4 Expression of Genes Associated with Senescence and Sphingolipid Biosynthesis,
Catabolism, and Homeostasis.
15 day-old wild-type plants and transgenic lines expressing LCB1C144W and LCB1C144W/V155D, were used to
examine gene expression by q-PCR to monitor the expression of (A) senescence-related 13 SAG13, (B)
ceramide synthase LOH2 (C) ORM1 (D) ORM2 and (E) DPL1. PP2AA3 transcript levels were used as a
control. Specific primers used for this analysis are shown in Supplemental Table 1 in Appendix B. Gene
expression levels are normalized to those in wild-type seedlings. Values are the mean ± SD (n=9). There
are no significant differences based on one-way ANOVA followed by Tukey´s multiple comparisons test.

Given that the plants expressing HSAN1-like mutations showed early senescence and
accumulation of C16 ceramides we then examined the expression SAG13, a senescencerelated gene, and LOH2, the gene encoding the ceramide synthase that preferentially Nacylates C16 fatty acids with LCBs to form ceramides. Our results revealed no significant
changes in the expression of these genes among the wild-type and transgenic lines
evaluated (Figures 4.4A and 4.4B). Similarly, the expression of ORM genes, regulators of
SPT activity; and DPL1, encoding the lyase that catabolizes LBCs, did not change in the
transgenic plants compared to wild-type (Figures 4.4C- 4.4E).
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4.5

Discussion

For this work, we hypothesized that the incorporation of the HSAN1 mutations into the
Arabidopsis LCB1 SPT subunit would enhance the production of deoxysphingolipids in
the plants. DeoxySA (m18:0) is normally present at very low concentrations in the wildtype and can be increased 60-fold in the orm1∆met/∆met orm2−/− mutant where SPT activity
is deregulated (Chapter 3). We picked C144W and V155D because they are among the
most frequent mutations in the context of HSAN1 and these residues are in a highly
conserved region of LCB1 that is predicted to be a catalytic domain (Bode et al., 2016).
Failure to complement the Atlcb1+/− mutant with LCB1C144W or LCB1 C144W/V155D
suggests the detrimental effects of these point mutations. Additional confirmation was
provided by the low germination rate of the progeny of heterozygous plants expressing
the mutations in LCB1. Notably, the germinated seeds gave rise to plants with an early
senescence phenotype, which was also observed in wild-type seedlings growing with
alanine supplementation. It has been shown that the formation of deoxysphingolipids is
modulated by the availability of alanine and serine. Increased alanine concentration
enhances the production of deoxysphingolipids in a HSAN1 mouse model and in mutantexpressing HEK293 cells (Garofalo et al., 2011; Bode et al., 2016). Therefore, one
possible explanation is that wild-type SPT can use alanine as substrate for the production
of deoxysohingolipids when this amino acid is in excess. In this context it will be
important to perform sphingolipid measurements for the detection of the free deoxyLCBs
(m18:0, m18:1) and their incorporation into ceramides in seedling grown with excess
alanine and serine. In this case, we would expect serine enrichment to alleviate the
senescence phenotype in the transgenic plants.
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Our findings showed that the senescence phenotype persisted in adult transgenic plants
and it was also associated with delayed flowering. Despite the observed phenotypes, the
adult transgenic plants did not accumulate deoxyceramides compared to wild type. Yet,
the detected deoxyLCBs were preferentially coupled with C16 fatty acids to form
deoxyceramides. This suggests channeling through the LOH2 ceramide synthase which
has substrate specificity for the more common dihydroxy LCBs. In contrast, mouse
fibroblasts incorporated supplemental m18:0 to a variety of acyl-CoAs from C16 to
C24:1; while m18:1 was preferentially acylated to VLCFA (Alecu et al., 2017).
Examination of gene expression showed no changes in LOH2 transcript levels in the
transgenic plants compared to wild type; perhaps other regulatory mechanisms at the
protein level could take place to favor the increase of C16 ceramides in chlorotic leaves.
Moreover, it will be interesting to determine if C16 ceramide accumulation also occurs
during senescence in wild-type plants.
Consistent with our findings, in mammalian cells the HSAN1-like mutations have been
linked to the aging process and induced expression of senescence markers (Lone et al.,
2019). Even though, gene expression analyses showed no differences in the transcript
levels of the senescence-related gene SAG13, it is necessary to complement the analysis
with other markers.
Until recently, deoxysphingolipids have been considered dead-end metabolites due to the
lack of the hydroxyl group at C1 position for canonical degradation. However, a recent
report described multiple polyunsaturated and polyhydroxylated forms of deoxySA as
catabolic downstream products (Alecu et al., 2017). It is possible that in plants
deoxysphingolipids are also degraded to other hydroxylated structures as a cellular
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detoxification process that requires further investigation. Another important aspect
related to the cellular effects of deoxysphingolipids is their subcellular localization.
A study revealed that an alkyne-click labelled deoxySA initially localizes to
mitochondria and it is later detected in Golgi and ER (Alecu et al., 2017). The
localization of these lipids to mitochondria induces changes in morphology and reduced
ATP generation (Alecu et al., 2017). Future work will focus on determining possible
downstream products of deoxysphingolipids in plants and their potential roles related to
mitochondrial dysfunction and senescence.
It is important to note that the effect of two HSAN1-related mutations, like in LCB1
C144W/V155D

, has not been investigated before; however, our current findings suggest there

is no synergistic effect when compared to the single mutation LCB1 C144W.
Out of the context of HSAN1, mammalian cells treated with FB1, a ceramide synthase
inhibitor, accumulated deoxySA showing that wild-type SPT was able to synthesize this
unusual structures (Zitomer et al., 2011). Moreover, FB1 treatment caused an increase in
deoxySA in HEK293 cells expressing SPTLC1C133W and this was accompanied with a
reduced SPT activity (Bode et al., 2016). Consistent with this, our results showed
transgenic seedlings expressing LCB1C144W and LCB1 C144W/V155D were resistant to the
cell death induced by FB1, possibly due to a decrease in SPT activity and reduced levels
of canonical cytotoxic LCBs. In order to elucidate if ORM proteins could be associated
with SPT regulation under FB1 treatment, we performed gene expression analyses. Our
results rule out the possibility of transcriptional regulation of ORM, but leave open other
options like specific ceramide species interacting with ORMs to exert the regulation of
SPT activity.
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One of the objectives of the present study was to introduce the HSAN1 mutations in the
Arabidopsis LCB1 to examine the feasibility of using deoxySA levels as a readout for
SPT activity. In yeast, this strategy has been successful and the concentration of this
atypical LCB has been used as an indirect measurement of activity (Gable et al., 2010). In
the case of Arabidopsis, more work is needed to determine if the free deoxyLCBs
(m18:0, m18:1) can be used for this purpose. Especially, it will be important to determine
the dynamics of the catabolic pathways. In addition, it will be interesting to explore if the
ORM proteins are involved in the regulation of SPT activity in response to the production
of deoxysphingolipids.
AUTHOR CONTRIBUTIONS
A.G.S., G.H., T.M.D., and E.B.C. designed the study; A.G.S. and R.E.C. performed the
experiments and analyzed the data.

90

4.6

References

Alecu, I., Othman, A., Penno, A., Saied, E.M., Arenz C., von Eckardstein, A.,
Hornemann, T. (2017) Cytotoxic 1-deoxysphingolipids are metabolized by a
cytochrome P450-dependent pathway, J. Lipid Res. 58:60–71.
Alecu, I., Tedeschi, A., Behler, N., Wunderling, K., Lamberz, C., Lauterbach, M.A.,
Gaebler, A., Ernst, D., Van Veldhoven, P.P., Al-Amoudi, A., Latz, E., Othman, A.,
Kuerschner, L., Hornemann, T., Bradke, F., Thiele, C., Penno, A. (2017)
Localization of 1-deoxysphingolipids to mitochondria induces mitochondrial dysfunction,
J. Lipid Res. 58:42–59.
Bode, H., Bourquin, F., Suriyanarayanan, S., Wei, Y., Alecu, I., Othman, A., Von
Eckardstein, A., Hornemann, T. (2016) HSAN1 mutations in serine
palmitoyltransferase reveal a close structure-function-phenotype relationship, Hum. Mol.
Genet. 25:853–865.
Chen, M., Han, G., Dietrich, C.R., Dunn, T.M., and Cahoon, E.B. (2006). The
essential nature of sphingolipids in plants as revealed by the functional identification and
characterization of the Arabidopsis LCB1 subunit of serine palmitoyltransferase. Plant
Cell 18: 3576–3593.
Clough, S.J., and Bent, A.F. (1998). Floral dip: A simplified method for
Agrobacterium-mediated transformation of Arabidopsis thaliana. Plant J. 16: 735–743.
Dawkins JL, Hulme DJ, Brahmbhatt SB, Auer-Grumbach M, Nicholson GA. (2001)
Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1,
cause hereditary sensory neuropathy type I. Nat Genet. 27:309-12.
Duan, J., & Merrill, A. H., Jr (2015). 1-Deoxysphingolipids Encountered Exogenously
and Made de Novo: Dangerous Mysteries inside an Enigma. J Biol Chem, 290:15380–
15389.
Dietrich, C.R., Han, G., Chen, M., Berg, R.H., Dunn, T.M., and Cahoon, E.B.
(2008). Loss-of-function mutations and inducible RNAi suppression of Arabidopsis
LCB2 genes reveal the critical role of sphingolipids in gametophytic and sporophytic cell
viability. Plant J. 54: 284–298.
Gable, K., Slife, H., Bacikova, D., Monaghan, E., and Dunn, T.M. (2000). Tsc3p is an
80-amino acid protein associated with serine palmitoyltransferase and required for
optimal enzyme activity. J. Biol. Chem. 275: 7597–7603.
Gable, K., Han, G., Monaghan, E., Bacikova, D., Natarajan, M., Williams, R., Dunn,
T. M. (2002) Mutations in the yeast LCB1 and LCB2 genes, including those
corresponding to the Hereditary Sensory Neuropathy type I mutations, dominantly
inactivate serine palmitoyltransferase J. Biol. Chem. 277:10194–10200.

91

Gable, K., Gupta, S.D., Han, G., Niranjanakumari, S., Harmon, J. M., Dunn, T.M.
(2010) A Disease-causing Mutation in the Active Site of Serine Palmitoyltransferase
Causes Catalytic Promiscuity J. Biol. Chem., 285:22846–22852.
Garofalo, K., Penno, A. and Schmidt, B.P. (2011) Oral L-serine supplementation
reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary
sensory autonomic neuropathy type 1. J. Clin. Invest. 14–16.
Hanada, K. (2003) Serine palmitoyltransferase, a key enzyme of sphingolipid
metabolism. Biochim. Biophys. Acta 1632:16–30
Kimberlin, A.N., Han, G., Luttgeharm, K.D., Chen, M., Cahoon, R.E., Stone, J.M.,
Markham, J.E., Dunn, T.M., and Cahoon, E.B. (2016). ORM expression alters
sphingolipid homeostasis and differentially affects ceramide synthase activity. Plant
Physiol. 172: 889–900
Kimberlin, A.N., Majumder, S., Han, G., Chen, M., Cahoon, R.E., Stone, J.M.,
Dunn, T.M., and Cahoon, E.B. (2013). Arabidopsis 56- amino acid serine
palmitoyltransferase-interacting proteins stimulate sphingolipid synthesis, are essential,
and affect mycotoxin sensitivity. Plant Cell 25: 4627–4639.
Lone, M.A., Santos, T., Alecu, I., Silva, L.C., Hornemann, T. (2019) 1Deoxysphingolipids. Biochim Biophys Acta Mol Cell Biol Lipids.1864:512-521
Markham, J.E., and Jaworski, J.G. (2007). Rapid measurement of sphingolipids from
Arabidopsis thaliana by reversed-phase highperformance liquid chromatography coupled
to electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom.
21: 1304–1314.
Penno, A., Reilly, M.M., Houlden, H., Laura, M., Rentsch, K., Niederkofler, V.,
Stoeckli, E.T., Nicholson, G., Eichler, F., Brown, R.H. Jr., von Eckardstein A.,
Hornemann T. (2010) Hereditary sensory neuropathy type 1 is caused by the
accumulation of two neurotoxic sphingolipids, J. Biol. Chem. 285:11178–11187.
Rotthier, A., Penno, A., Rautenstrauss, B., Auer-Grumbach, M., Stettner, G.M.,
Asselbergh, B., Van Hoof K., Sticht, H., Levy, N., Timmerman, V., Hornemann, T.,
Janssens K. (2011) Characterization of two mutations in the SPTLC1 subunit of serine
palmitoyltransferase associated with hereditary sensory and autonomic neuropathy type I,
Hum. Mutat. 32:E2211–E2225.
Tamura, K., Musuhashi, M., Hara-Nishimura, I., and Imai, H. (2001).
Characterization of an Arabidopsis cDNA encoding a subunit of serine
palmitoyltransferase, the initial enzyme in sphingolipid biosynthesis. Plant Cell Physiol.
42:1271–1281.

92

Williams, R. D., E. Wang, and A. H. Merrill, Jr. (1984) Enzymology of long-chain
base synthesis by liver: characterization of serine palmitoyltransferase in rat liver
microsomes. Arch. Biochem. Biophys. 228:282–291.
Zitomer, N.C., Mitchell, T., Voss, K.A, Bondy, G.S., Pruett, S.T., GarnierAmblard, E.C., Liebeskind, L.S., Park, H., Wang, E., Sullards, M.C., Merrill Jr
A.H., Riley R.T. (2009) Ceramide synthase inhibition by fumonisin B1 causes
accumulation of 1-deoxysphinganine: a novel category of bioactive 1-deoxysphingoid
bases and 1-deoxydihydroceramides biosynthesized by mammalian cell lines and
animals, J. Biol. Chem. 284:4786–4795.

93

5

Chapter 5 Towards Building a Kinetic Model of Sphingolipid Biosynthesis
under FB1 Treatment and Pathogen Infection.

This chapter may be part of a publication in the future.
Authors: Ariadna Gonzalez Solis, Adil Alsiyabi, Jennifer E. Markham, Edgar B. Cahoon,
Rajib Saha.
5.1

Abstract

The fungal mycotoxin FB1 and the avirulent pathogen Pseudomonas syringae pv. tomato
avrRpm1 elicit a rapid increase in LCBs and their phosphorylated forms in Arabidopsis.
In the case of FB1 treatment, this buildup of LCBs is the consequence of the inhibition of
ceramide synthases that condense LCBs and fatty acids for the formation of ceramides. In
contrast, the main mechanisms of the accumulation of LCBs are not known during
pathogen infection. Here we characterize the Arabidopsis cell suspension culture as a
system for the generation of a metabolic model that will allow a better understanding of
the changes in sphingolipid network in the context of FB1 treatment and pathogen
infection.
5.2

Introduction

In addition to the structural roles of glycosphingolipids (GlcCer and GIPCs) in membrane
formation and function; sphingolipid biosynthetic intermediates (LCBs and ceramides)
have been recognized as important mediators of physiological processes in plants.
Phosphorylated long chain bases (LCBs-P) participate in the ABA-mediated signaling
pathway that regulate stomatal closure (Ng et al., 2001; Coursol et al., 2003, 2005;
Townley et al., 2005). Whereas several studies revealed LCBs and ceramides as inducers
of programmed cell death (PCD). This association has been shown in Arabidopsis
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mutants that accumulate ceramides (Liang et al., 2003; Bi et al., 2014); with exogenously
applied LCBs and ceramides (Lachaud et al., 2010, Alden et al., 2011) or with Fumonisin
B1 (FB1) treatment (Stone et a., 2000; Shi et al., 2007; Saucedo-García et al., 2011).
FB1 is a sphingosine-analogue mycotoxin produced by Fusarium species. It is widely
known as a potent inhibitor of ceramide synthases that triggers the accumulation of LCBs
(Abbas et al., 1994). Recent evidence suggests this mycotoxin exerts a more effective
inhibition on Class II ceramide synthases (LOH1 and LOH3) that generate ceramides
with VLCFA, than Class I (LOH2) which preferentially produces C16-containing
ceramides (Markham et al., 2011; Ternes et al., 2011; Luttgeharm et al., 2016).
Therefore, the PCD induced by FB1 is presumably due to the accumulation of LCBs and
C16 ceramides.
A successful immune response in plants often includes the hypersensitive response (HR),
a form of rapid programmed cell death (PCD) occurring in a limited area at the site of
infection (Balint-Kurti, 2019). This suicide of infected cells is thought to limit the spread
of biotrophic pathogens that rely on the plant cell machinery for proliferation (Mur et al.,
2010). Given the similarities of FB1- and pathogen- induced PCD it is believed that
LCBs and ceramides are part of the large array of signaling networks involved in plant
resistance (Berkey, 2012). Notably, infection of Arabidopsis with the avirulent pathogen
Pseudomonas syringae pv. tomato avrRpm1 triggers the accumulation of LCB
phytosphingosine (t18:0) (Peer at al., 2010). Furthermore, the ceramide accumulation in
acd5 and acd11 mutants is associated with salicylic acid- dependent upregulation of
defense-related genes (Brodersen et al., 2002). However, the mechanisms for the
induction of LCB and ceramides during pathogen attack are not known. It is possible that
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the immune response mechanisms are linked to an altered regulation of SPT to induce de
novo synthesis of sphingolipids (Takahashi et al., 2009). Alternatively, catabolic
reactions including the degradation of more complex sphingolipids like GIPCs and
GlcCer could give rise to enhanced levels of free LCBs and ceramides.
In this work, we characterized the Arabidopsis T87 cell line as a system to perform
metabolic labeling to determine the changes in sphingolipid levels in response to FB1 and
pathogen infection. This system will be used to generate data to create a kinetic model
that will allow a better understanding of the changes in the metabolic network. The
combination of experimental testing and in silico analysis will allow refinement of the
model to make predictions of cell responses under different perturbations.
5.3

Materials and Methods

5.3.1

Plant Material and Growth Conditions.

An undifferentiated and photoautotrophic Arabidopsis thaliana T87 cell suspension
culture, established from the ecotype Columbia (Axelos et al., 1992), was used in this
study. Cells were cultured in NT-1 liquid medium (Murashige and Skoog medium with
vitamins, 30 g/l sucrose, 1 mM KH2PO4, 1mg/l thiamine, 100mg/l myo-inosytol and
2 µM 2,4-dichlorophenoxyacetic, pH 5.8 adjusted with KOH) at 22 °C and 120 rpm on a
shaking platform under continuous light conditions (100µmol/ m-2 s-1). Every 7 days 1
ml of mother cell suspension was transferred into 50 ml of fresh medium.
5.3.2

Stable Isotope Labeling

T87 Arabidopsis cells were cultured in NT-1 liquid medium containing
K15NO3 and 15NH415NO3 (Cambridge Isotope Labs) under the same conditions described
above.
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5.3.3

Fumonisin B1 Treatment

The cells were grown for 2 d first in NT-1 medium and then FB1 (Sigma-Aldrich) was
added for a final concentration of 1µM. The cells were sampled for analysis after 1, 2, 4,
6, 12, 24, 48 and 72 h. Control cells were also sampled at the same point of time. Cells
were harvested by centrifugation at 400g for 5 min and lyophilized prior to sphingolipid
analysis.
5.3.4

Sphingolipid Extraction and Analysis.

Sphingolipids were extracted as described in Markham and Jaworski (2007). Briefly, 10
to 30 mg of lyophilized cells were homogenized and extracted with
isopropanol:heptane:water (55:20:25, v/v/v). Internal standards for the different
sphingolipid classes were added. The supernatants were dried and deesterified with
methylamine in ethanol:water (70:30, v/v). The lipid extract was re-suspended in
tetrahydrofuran:methanol:water (5:2:5, v/v/v) containing 0.1% (v/v) formic acid. The
sphingolipid species were analyzed using a Shimadzu Prominence ultra-performance
liquid chromatography system and a 4000 QTRAP mass spectrometer (AB SCIEX). The
incorporation of the 15N into sphingolipid was detected with a +1 m/z shift in the mass of
both the precursor and the product ion in sphingolipid MRMs. Data analysis and
quantification were performed using the software Analyst 1.5 and MultiQuant 2.1 as
described by Markham and Jaworski (2007), Kimberlin et al. (2013).
5.4

Results

A time-course sphingolipid profiling was conducted to characterize the response of the
Arabidopsis cells to FB1. The accumulation of free LCBs was observed from two hours
of treatment with the mycotoxin and was sustained over all the time points analyzed

97

(Figures 5.1A-C and 2A-H). Free LCBs, mainly d18:0 and t18:0, accumulated 17-fold
during the first six hours of treatment compared to the control (Figure 5.1A-C and 5.2AD). While after 24, 48 and 72 hours, the phosphorylated forms (LCB-P), d18:0-P and
t18:0-P, reached levels of 36- 203- and 280-fold, respectively, compared to the control
(Figures 5.1B-C and 5.2A-H). In addition, treatment with FB1 resulted in a reduction of
~half the amount of the original level of ceramides at two hours and was maintained until
six hours post treatment. We observed an increase in C16 ceramides at 24 hours after
exposure to FB1.

Figure 5.1 Time course sphingolipid profiling of Arabidopsis T87 cells after treatment with 1µM
FB1.
(A) Total levels of free LCBs and the phosphorylated forms (LCB-P). Distribution of free or
phosphorylated LCBs at the different time points analyzed for (B) control and (C) 1µM FB1. (D) Total
levels of ceramides. Distribution of ceramides containing (E) very long chain fatty acids (VLCFA) or (F)
C16 fatty acids. Time 0 h corresponds to the basal levels before FB1 addition.
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To establish if the stable isotope labeling with 15N is a suitable method to detect changes
in fluxes of sphingolipids, we first determined the growth rate of the Arabidopsis cells in
medium where the nitrogen sources have been replaced with 15N. According to the results
the 15N medium did not affect the growth of the cells (Figure 5.3A). Next, to determine if
we can detect the label going to sphingolipids we measured labeled LCBs and ceramides
after 18 hours of growing in 15N medium. We observed an incorporation of the isotope
into LCBs and ceramides in cells and this incorporation was blocked with the SPT
inhibitor, myriocin.

Figure 5.2 Time course profiling of LCBs and LCB-P.
Time course analysis of the indicated (A-D) free LCBs and (E-H) phosphorylated LCBs (LCB-P) levels in
Arabidopsis T87 cells after treated with 1µM FB1.
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Figure 5.3 Labeling of Sphingolipids with the Stable Isotope Nitrogen 15.
(A) Growth curve of T-87 cells cultured with nitrogen 14 (14N) or the stable isotope nitrogen 15 (15N).
Values are the mean ±SD (n=3). (B) Incorporation of 15N into ceramides and LCBs of wild type cultured
cells treated with DMSO as control and 1 nM myriocin for 18 hours. Values are the mean ±SD (n=3).
Asterisks denote statistical significance when P < 0.01 in Students' T Test.

5.5

Discussion

For our studies, we chose the photoautotrophic Arabidopsis T87 cell culture because it
has a short doubling time (2.7 days), produces large amount of tissue and it is a good
system to perform in vivo labeling with reduced biological variation.
Consistent with previous studies performed in plants (Saucedo-Garcia et al., 2011; Peer et
al., 2010), treatment of the Arabidopsis cell suspension with FB1 elicited a rapid
accumulation of free LCBs and the phosphorylated forms. Moreover, as expected, we
observed a reduction in ceramide levels following FB1 exposure and a subsequent
accumulation of C16 ceramides at longer times (>24 h). These results confirm the early
response of the cells to FB1 and validate it as a good system for the labeling studies.
We could also detect the incorporation of the nitrogen 15 isotope into LCBs and
ceramides via flux through SPT in short-term experiments, thus this is a cost effective
and accurate procedure that can be used in quantitative profiling to apply to a kinetic
model. The rate at which 15N appears in sphingolipids will be used to calculate the fluxes
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trough each step of the pathway using a reaction network that comprises all the metabolic
transformations involved in sphingolipid biosynthesis in Arabidopsis (Alsiyabi et al.,
2010 under revision). Especially, this labeling approach will be very informative to
estimate sphingolipid turnover rates. The kinetic model will allow us to make predictions
of how the flux of sphingolipid metabolites is regulated in response environmental
responses.
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APPENDIX A

Supplemental Figure 1. Predicted Protein Sequences of ORMs in the CRISPR/Cas9 Mutants.
Predicted protein sequences based on indels. (A) ORM1, for the single mutant orm1−/− and the double
knockout orm1−/− orm2−/−, the deletion of one nucleotide in the first exon resulted in a frameshift in the
coding sequence that produced premature termination. In the case of orm1∆met/∆met orm2−/− the deletion of
three nucleotides resulted in the elimination of a methionine residue at position 51. (B) ORM2, for the
single mutant orm2−/− and double mutants, the deletion of four nucleotides caused a frameshift and
premature termination of the polypeptide.
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Supplemental Figure 2. PCR/Digestion-based Genotyping of CRISPR/Cas9 ORM Mutants.
The DNA fragment encompassing the CRISPR target site was amplified by PCR (Primers P5-P8) and
digested with BslI (ORM1) or DraIII (ORM2).
(A) Representative genotyping results of wild-type Col-0 and orm1+/− orm2+/−.
(B) Representative genotyping results of wild-type Col-0, orm1−/−, orm2−/−, orm1∆met/∆met orm2+/− and
orm1∆met/∆met orm2−/−. In wild-type plants, the DNA is completely digested at the restriction site. In
homozygous plants, the restriction site was lost by CRISPR/Cas9-induced mutation, resulting in undigested
DNA. In heterozygous plants, the restriction site is present in one gene copy, resulting in partial digestion.
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Supplemental Figure 3. Complementation of orm1met/met orm2−/−.
(1) Wild-type plant, (2-8) orm1∆met/∆met orm2−/− plants complemented with a codon optimized version of
ORM1 under the control of its native promoter.
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Supplemental Figure 4. Ceramide Compositions with Hydroxylated Fatty Acids in ORM Mutants.
Concentrations of ceramides with hydroxylated fatty acids (hCer) are presented according to the
composition of LCB (d18:0, d18:1, t18:0, t18:1) and hydroxylated (h) fatty acid for (A) wild-type Col-0,
(B) orm1−/−, (C) orm2−/−, (D) orm1∆met/∆met orm2+/− and (E) orm1∆met/∆met orm2−/−. Bars show averages of four
to six replicates consisting of 12 to 15-day-old pooled seedlings grown on different plates. Error bars
represent the standard error of the mean.
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Supplemental Figure 5. Glucosylceramide Compositions in ORM Mutants.
Glucosylceramide (GlcCer) concentrations are presented according to the composition of LCB (d18:0,
d18:1, t18:0, t18:1) and hydroxylated (h) fatty acid for (A) wild-type Col-0, (B) orm1−/−, (C) orm2−/−, (D)
orm1∆met/∆met orm2+/− and (E) orm1∆met/∆met orm2−/−. Bars show averages of four to six replicates consisting of
12 to 15-day-old pooled seedlings grown on different plates. Error bars represent the standard error of the
mean.
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Supplemental Figure 6. Composition of Glucosylceramides Containing Non-Hydroxylated Fatty Acids in
ORM Mutants.
Concentrations of glucosylceramides containing non-hydroxylated fatty acids (nh-GlcCer) are presented
according to the composition of LCB (d18:0, d18:1, t18:0, t18:1) and fatty acid for (A) wild-type Col-0, (B)
orm1−/−, (C) orm2−/−, (D) orm1∆met/∆met orm2+/− and (E) orm1∆met/∆met orm2−/−. Bars show averages of four to
six replicates consisting of 12 to 15-day-old pooled seedlings grown on different plates. Error bars
represent the standard error of the mean.
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Supplemental Figure 7. Glycosylinositolphosphoceramide Compositions in ORM Mutants.
Glycosylinositolphosphoceramide (GIPC) concentrations are presented according to the composition of
LCB (d18:0, d18:1, t18:0, t18:1) and the hydroxylated (h) fatty acid for (A) wild-type Col-0, (B) orm1−/−,
(C) orm2−/−, (D) orm1∆met/∆met orm2+/− and (E) orm1∆met/∆met orm2−/−. Bars show averages of four to six
replicates consisting of 12 to 15-day-old pooled seedlings grown on different plates. Error bars represent
the standard error of the mean.
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Supplemental Figure 8. Expression of Genes Associated with Sphingolipid Biosynthetic and Catabolic
Pathways and Pathogenesis.
Wild-type, orm1−/−, orm2−/−, orm1∆met/∆met orm2+/− and orm1∆met/∆met orm2−/−seedlings (12-day-old plants)
were used to examine gene expression by qPCR to monitor genes encoding enzymes in the sphingolipid
biosynthetic and catabolic pathways: (A) LCB1, (B) ssSPTa, (C) ceramide synthase gene LOH1, (D)
sphingosine kinase 1 gene SPHK1; and the selected pathogenesis-related gene (E) basic chitinase PR3.
PP2AA3 transcript levels were used as a control for the sphingolipid genes and UBIQUITIN for the
pathogenesis-related genes. Specific primers used for this analysis are shown in Supplemental Table 1.
Gene expression levels are normalized to those in wild-type seedlings. Values are the mean ± SD (n=6-12).
Different letters indicate significant difference based on one-way ANOVA followed by Tukey’s multiple
comparisons test (P≤0.05).

112

Supplemental Figure 9. Amino Acid Sequence Alignment of ORM Proteins.
Protein sequences from Saccharomyces cerevisiae (Sc), Arabidopsis thaliana (At) and Homo sapiens
(ORMDL). The dashed lines indicate putative transmembrane domains. Methionine 51 in AtORM1 is
highlighted (green) as well as conserved amino acids (yellow).
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Supplemental Table 1. Primer Sequences Used for Cloning, RT-PCR, qPCR, and Genotyping.
Prim
er
P1

Primer
Name
ORM1-BsF

P2

ORM1-F1

P3

ORM2-R1

P4

ORM2-BsR

P5

ORM1-F

5’ATATATGGTCTCGATTGTTGTTCCCCTGGAATGGCTGT
T-3’
5’TGTTGTTCCCCTGGAATGGCTGTTTTAGAGCTAGAAAT
AGC-3’
5’AACCTCTGTGTTCCGATTCACACAATCTCTTAGTCGAC
TCTAC-3’
5’ATTATTGGTCTCGAAACCTCTGTGTTCCGATTCACACA
A-3’
5’-GAAATGGCGAATCTGTATG-3’

P6

ORM1-R

5’-CATCATCTAATTTAAAGTCAC-3’

P7

ORM2-F

5’-CTTGCTCAACGACGATTCAT-3’

P8

ORM2-R

5’-GAGGAGATCGGGAATAATAC-3’

P9
P10
P11

Cas9-F
Cas9-R
A_OptORM1
F

5’-CTGTTCGTCGAGCAGCACAAGCATT-3’
5’ TTCCCAATGCCATAATACTCAAACTCAG-3’

B_OptORM1r
C_OptORM1f

5’-CAGTCCATGCCATACCTGGAGAGCAACCAGAG-3’
5’-CTCTGGTTGCTCTCCAGGTATGGCATGGACTG-3’

D_OptORM1
R
ORM1promot
erF
ORM1promot
erR
PP2AA3
(At1g13320)
LOH1
(At3g25540)
LOH2
(At3g19260)
LOH3
(At1g13580)
LCB1
(At4g36480)
ssSPTa
(At1g06515)
DPL1qpcr-F
DPL1qpcr-R
Sphk1-qpcr-F
Sphk1-qpcr-R
Sphk2-qpcr-F
Sphk2-qpcr-R
PRXc-qpcr-F
PRXc-qpcr-R
PR2-qpcr-F
PR2-qpcr-R

5’-ATGCTCTAGATTATTTATCACCATTG-3’

P12
P13
P14
P15
P16
P17
P18
P19
P20
P21
P22
P23
P24
P25
P26
P27
P28
P29
P30
P31
P32

Sequence
Cloning
BsaI
Cloning
Cloning
Cloning
BsaI

QuantiTect Qiagen QT00857220

Genotypin
g
Genotypin
g
Genotypin
g
Genotypin
g
Cas9 check
Cas9 check
Cloning
EcoRI
Overlappin
g PCR
Overlappin
g PCR
Cloning
XbaI
Cloning
BamHI
Cloning
EcoRI
qPCR

QuantiTect Qiagen QT00779331

qPCR

QuantiTect Qiagen QT00774949

qPCR

QuantiTect Qiagen QT00857402

qPCR

QuantiTect Qiagen QT00727251

qPCR

QuantiTect Qiagen QT01712004

qPCR

5’-GCTTGGTCAACTGGCTCTTA-3’
5’-GGGATCTGGTACCCAAGTTTAC-3’
5’-AGACCTTGGTTGAGAAAGGAGGAG-3’
GATGGAACTTATCGGACCAAAGCT
CGGTGGACAGAGTATGGACTCC
GCAGCAGATTCCTCCTGCCT
5’-CAACATCGTCCACTTGGACAATCTT-3’
5’-CCTGCCAAAGTGACAGATTGTTGAG-3’
5’-AGCCTCACCACCAATGTTGATGAT-3’
5’-GTTCTCGATGTTCTGCATTGCTTGT-3’

qPCR
qPCR
qPCR
qPCR
qPCR
qPCR
qPCR
qPCR
qPCR
qPCR

5’-ATGCGAATTCATGGCGAATCTGTATGTGA-3’

5’-ATGCGGATCCCTTTGGCTGCACTCCTCTCT-3’
5’-ATGCGAATTCTTCTTCTTCAATCAGATCGGATCG -3’

114
P33
P34
P35
P36
P37
P38

PR3-qpcr-F
5’-AACGGTCTATGCTGCAGCGAGTT-3’
PR3-qpcr-R
5’-GCGCTCGGTTCACAGTAGTCTGA-3’
FMO-qpcr-F
5’-CGTATTCGAAGCCTCGGATTCAGTC-3’
FMO-qpcr-R
5’-GGTATTCTTGGAACGTCGCCGTATT-3’
SAG13-qpcr-F 5’-GAAACTCAGCTTCAAGAACGCTTACGTG-3’
SAG13-qpcr5’-TCGCCCATTCGCAAGCTAAGTTT-3’
R
Underlined sequences correspond to the restriction enzyme sites.

qPCR
qPCR
qPCR
qPCR
qPCR
qPCR

115

7

APPENDIX B

Supplemental Figure 1. Amplification with gene specific primers (P2+P3 Supplemental Table 1,
Appendix B) indicate wild type LCB1, while amplification with T-DNA primers (P1+P3) indicate the
presence of the T-DNA. A PCR product amplified with both primer sets indicates heterozygous line.
Amplification with only gene specific primers corresponds to wild type.
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Supplemental Figure 2. 30 days-old representative plants (A) Col-0 and (B) LCB1C144W
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Supplemental Table 1. Primer Sequences Used for Genotyping and qPCR.
Primer

Primer
Name

Sequence

P1

Lb1a

5’-TGGTTCACGTAGTGGGCCATCG-3’

Genotyping

P2

F1

5’-GATGGCTTCATGTAATGTTTGTACTTTC-3’

Genotyping

P3

R

5’-TGGTGGCTCATGCTTCATGTC-3’

Genotyping

P4

PP2AA3
(At1g13320)
LOH2
(At3g19260)
SAG13-qPCRF
SAG13-qPCRR

QuantiTect Qiagen QT00857220

qPCR

QuantiTect Qiagen QT00774949

qPCR

5’-GAAACTCAGCTTCAAGAACGCTTACGTG3’
5’-TCGCCCATTCGCAAGCTAAGTTT-3’

qPCR

ORM1-qPCR-F

5’-AATGGTCAACAGCTTACCCGCAA-3’

qPCR

P9

ORM1-qPCR-R

5’-TATGCGATGCAATCAAGTACAGAACAAC3’

qPCR

P10

ORM2-qPCR-F

5’-TTGATAATGGCAAGCAGCTTACACGTA-3’

qPCR

P11

ORM2-qPCR-R

5’ATCAAGTACAAGACAACAGGAACAACGG-3’

qPCR

P5
P6
P7
P8

qPCR

